Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	modification-dependent protein binding	RNF169 NANOGP8 ANK2 NANOG PHF2 BPTF PHF20L1 SETD5 TAF1 HDGFL2	6.89e-06	206	161	10	GO:0140030
GeneOntologyMolecularFunction	methylation-dependent protein binding	PHF2 BPTF PHF20L1 SETD5 TAF1 HDGFL2	7.86e-05	88	161	6	GO:0140034
GeneOntologyMolecularFunction	actin binding	FLII EVL LIMA1 AKAP5 CEACAM5 MAP2 BCL7B TRIOBP MYO3A CLMN AFDN LIMCH1 EPB41L2	1.41e-04	479	161	13	GO:0003779
GeneOntologyMolecularFunction	histone binding	NANOGP8 NANOG NAP1L3 PHF2 BPTF RESF1 SETD5 TAF1 HDGFL2	3.08e-04	265	161	9	GO:0042393
GeneOntologyMolecularFunction	RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity	NANOGP8 NANOG	3.84e-04	4	161	2	GO:0001010
GeneOntologyMolecularFunction	GTPase activator activity	RGPD2 RANBP3 RGPD1 OCRL ARHGAP11A BCR SRGAP3 RGPD3 ARHGAP21	4.48e-04	279	161	9	GO:0005096
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD2 RGPD1 RGPD3	5.30e-04	20	161	3	GO:0061665
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SETX ZGRF1 CHD9 RFC1 BPTF TOP2B	5.80e-04	127	161	6	GO:0008094
GeneOntologyMolecularFunction	dATP binding	ST13 ST13P5	6.36e-04	5	161	2	GO:0032564
GeneOntologyMolecularFunction	H3K27me3 modified histone binding	TAF1 HDGFL2	6.36e-04	5	161	2	GO:0061628
GeneOntologyMolecularFunction	methylated histone binding	PHF2 BPTF SETD5 TAF1 HDGFL2	6.59e-04	86	161	5	GO:0035064
GeneOntologyMolecularFunction	adenyl deoxyribonucleotide binding	ST13 ST13P5	9.49e-04	6	161	2	GO:0032558
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	CUL1 RNF169 NANOGP8 ATN1 ANK2 BCLAF1 NANOG DAB2 CNTLN ST13 PHF2 FZR1 SETD5 ATF7IP NCOA1 KDM2A SPEN HDGFL2 NIPBL THRAP3	1.08e-03	1160	161	20	GO:0030674
GeneOntologyMolecularFunction	small GTPase binding	RGPD2 RANBP3 RGPD1 TRIOBP OCRL RAB11FIP1 SYTL5 RGPD3 AFDN	1.21e-03	321	161	9	GO:0031267
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	SETX ZGRF1 CHD9 RFC1 BPTF TDP1 NIPBL TOP2B	1.32e-03	262	161	8	GO:0140097
GeneOntologyMolecularFunction	purine deoxyribonucleotide binding	ST13 ST13P5	1.32e-03	7	161	2	GO:0032554
GeneOntologyMolecularFunction	molecular adaptor activity	CUL1 USP18 RNF169 NANOGP8 AKAP5 ATN1 ANK2 BCLAF1 NANOG DAB2 CNTLN ST13 PHF2 FZR1 SETD5 ATF7IP NCOA1 KDM2A SPEN HDGFL2 NIPBL THRAP3	1.33e-03	1356	161	22	GO:0060090
GeneOntologyMolecularFunction	cytoskeletal protein binding	FLII EVL LIMA1 AKAP5 CEACAM5 ANK2 MAP2 MARK3 HSPH1 BCL7B APC TRIOBP MYO3A CLMN STARD9 CCSER2 AFDN LIMCH1 EPB41L2	1.40e-03	1099	161	19	GO:0008092
GeneOntologyMolecularFunction	lysine-acetylated histone binding	NANOGP8 NANOG TAF1	1.78e-03	30	161	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	NANOGP8 NANOG TAF1	1.96e-03	31	161	3	GO:0140033
GeneOntologyBiologicalProcess	regulation of chromatin organization	TLK2 PHF2 TLK1 RESF1 SETD5 ATF7IP	5.69e-07	40	158	6	GO:1902275
GeneOntologyBiologicalProcess	DNA damage response	TLK2 RNF169 SETX RBBP6 BCLAF1 ZGRF1 BCL7B APC E2F7 RFC1 PALB2 PPP4R3A FZR1 TLK1 STK33 ZBTB40 KDM2A BOD1L1 TAF1 TDP1 HDGFL2 NIPBL TOP2B	1.16e-06	959	158	23	GO:0006974
GeneOntologyBiologicalProcess	regulation of stem cell division	NANOGP8 NANOG EVI2B PRDM15	9.33e-06	18	158	4	GO:2000035
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD2 RGPD1 RGPD3	3.58e-05	9	158	3	GO:0033133
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD2 RGPD1 RGPD3	5.09e-05	10	158	3	GO:1903301
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	FLII EVL LIMA1 MAP2 APC TRIOBP	6.32e-05	89	158	6	GO:1901880
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD2 RGPD1 RGPD3	1.19e-04	13	158	3	GO:0033131
GeneOntologyBiologicalProcess	negative regulation of protein-containing complex disassembly	FLII EVL LIMA1 MAP2 APC TRIOBP	1.21e-04	100	158	6	GO:0043242
GeneOntologyBiologicalProcess	protein depolymerization	FLII EVL LIMA1 MAP2 APC TRIOBP NCKAP5	1.24e-04	144	158	7	GO:0051261
GeneOntologyBiologicalProcess	regulation of protein-containing complex disassembly	FLII EVL LIMA1 SETX MAP2 APC TRIOBP	1.24e-04	144	158	7	GO:0043244
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD2 RGPD1 RGPD3	1.51e-04	14	158	3	GO:1903299
GeneOntologyBiologicalProcess	regulation of protein depolymerization	FLII EVL LIMA1 MAP2 APC TRIOBP	1.58e-04	105	158	6	GO:1901879
GeneOntologyBiologicalProcess	chromatin organization	TLK2 MBD1 BCL7B NAP1L3 CHD9 PCGF5 NSD3 PHF2 BPTF TLK1 RESF1 SETD5 ATF7IP NCOA1 KDM2A TAF1 HDGFL2 NIPBL	1.80e-04	896	158	18	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	MBD1 BCL7B NAP1L3 CHD9 PCGF5 NSD3 PHF2 BPTF RESF1 SETD5 ATF7IP NCOA1 KDM2A TAF1 HDGFL2 NIPBL	1.87e-04	741	158	16	GO:0006338
GeneOntologyBiologicalProcess	double-strand break repair	RNF169 SETX ZGRF1 BCL7B PALB2 KDM2A TDP1 HDGFL2 NIPBL TOP2B	2.05e-04	324	158	10	GO:0006302
GeneOntologyCellularComponent	nuclear protein-containing complex	TCEA1 RGPD2 BCLAF1 RANBP3 BCL7B RGPD1 E2F7 NOL11 SAGE2P PCGF5 ORC2 BPTF FZR1 UPF2 SETD5 CLMN RGPD3 NCOA1 BOD1L1 TAF1 NIPBL THRAP3 AFF4 EPB41L2 SMG6 RBM17	1.36e-05	1377	158	26	GO:0140513
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD2 RGPD1 RGPD3	2.31e-05	8	158	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD2 RGPD1 RGPD3	4.89e-05	10	158	3	GO:0044614
GeneOntologyCellularComponent	annulate lamellae	RGPD2 RGPD1 RGPD3	1.45e-04	14	158	3	GO:0005642
GeneOntologyCellularComponent	CA3 pyramidal cell dendrite	MAP2 TNN	1.69e-04	3	158	2	GO:0097442
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD2 RGPD1 RGPD3	3.18e-04	18	158	3	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD2 RGPD1 RGPD3	4.39e-04	20	158	3	GO:0042405
GeneOntologyCellularComponent	exon-exon junction complex	UPF2 THRAP3 SMG6	5.10e-04	21	158	3	GO:0035145
GeneOntologyCellularComponent	SUMO ligase complex	RGPD2 RGPD1 RGPD3	5.10e-04	21	158	3	GO:0106068
GeneOntologyCellularComponent	microtubule organizing center	CEP104 FLII RBBP6 ANKRD26 APC TRIOBP CEP192 CNTLN PCGF5 PPP4R3A ORC2 RESF1 CEP89 STARD9 RTRAF CEP126 CEP97	6.04e-04	919	158	17	GO:0005815
GeneOntologyCellularComponent	perinuclear region of cytoplasm	TLK2 RGPD2 AKAP5 ATN1 ANK2 PCLO RGPD1 DAB2 APC TSNAX BPTF KCNB1 UPF2 RTRAF STK33 RGPD3 SPINK5	7.23e-04	934	158	17	GO:0048471
GeneOntologyCellularComponent	centrosome	CEP104 FLII RBBP6 ANKRD26 APC TRIOBP CEP192 CNTLN PCGF5 PPP4R3A ORC2 CEP89 RTRAF CEP126 CEP97	7.59e-04	770	158	15	GO:0005813
HumanPheno	Thin upper lip vermilion	TLK2 ATN1 APC OCRL BCR BPTF SETD5 TAF1 SPEN NIPBL UNC80 AFF4	3.88e-05	339	47	12	HP:0000219
HumanPheno	Thin lips	TLK2 ATN1 APC OCRL BCR BPTF SETD5 TAF1 SPEN NIPBL UNC80 AFF4	3.88e-05	339	47	12	HP:0000213
HumanPheno	Abnormality of upper lip vermillion	TLK2 FLII ATN1 APC OCRL BCR BPTF EDAR SETD5 TAF1 SPEN NIPBL UNC80 AFF4	4.53e-05	464	47	14	HP:0011339
HumanPheno	Synophrys	FLII ZBTB20 BPTF SETD5 PLCB4 TAF1 SPEN NIPBL AFF4	5.65e-05	195	47	9	HP:0000664
HumanPheno	High, narrow palate	ATN1 PCLO APC BCR TAF1 SPEN NIPBL AFF4	7.36e-05	156	47	8	HP:0002705
HumanPheno	Narrow palate	ATN1 PCLO APC OCRL BCR TAF1 SPEN NIPBL AFF4	7.45e-05	202	47	9	HP:0000189
HumanPheno	Facial hypertrichosis	FLII ZBTB20 BPTF SETD5 PLCB4 TAF1 SPEN NIPBL AFF4	8.68e-05	206	47	9	HP:0002219
Domain	Ran_BP1	RGPD2 RANBP3 RGPD1 RGPD3	2.37e-06	12	159	4	PF00638
Domain	RANBD1	RGPD2 RANBP3 RGPD1 RGPD3	2.37e-06	12	159	4	PS50196
Domain	RanBD	RGPD2 RANBP3 RGPD1 RGPD3	3.41e-06	13	159	4	SM00160
Domain	Ran_bind_dom	RGPD2 RANBP3 RGPD1 RGPD3	3.41e-06	13	159	4	IPR000156
Domain	Rab_bind	RGPD2 RGPD1 RGPD3	2.07e-05	7	159	3	PF16704
Domain	GCC2_Rab_bind	RGPD2 RGPD1 RGPD3	2.07e-05	7	159	3	IPR032023
Domain	-	EVL RGPD2 RANBP3 RGPD1 DAB2 TRIOBP BCR PPP4R3A RGPD3 PLEKHA5 PLCB4 ARHGAP21 EPB41L2	3.11e-05	391	159	13	2.30.29.30
Domain	-	RGPD2 RGPD1 RGPD3	6.95e-05	10	159	3	1.10.220.60
Domain	PH_dom-like	EVL RGPD2 RANBP3 RGPD1 DAB2 TRIOBP BCR PPP4R3A RGPD3 PLEKHA5 PLCB4 ARHGAP21 EPB41L2	7.46e-05	426	159	13	IPR011993
Domain	Grip	RGPD2 RGPD1 RGPD3	9.50e-05	11	159	3	SM00755
Domain	GRIP	RGPD2 RGPD1 RGPD3	9.50e-05	11	159	3	PF01465
Domain	GRIP_dom	RGPD2 RGPD1 RGPD3	1.26e-04	12	159	3	IPR000237
Domain	GRIP	RGPD2 RGPD1 RGPD3	1.26e-04	12	159	3	PS50913
Domain	RhoGAP	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	1.84e-04	62	159	5	SM00324
Domain	RhoGAP	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	1.98e-04	63	159	5	PF00620
Domain	RhoGAP_dom	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	2.14e-04	64	159	5	IPR000198
Domain	RHOGAP	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	2.14e-04	64	159	5	PS50238
Domain	-	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	2.14e-04	64	159	5	1.10.555.10
Domain	THRAP3_BCLAF1	BCLAF1 THRAP3	2.15e-04	3	159	2	IPR029199
Domain	DUF3496	ANKRD26 CCDC144A	2.15e-04	3	159	2	IPR021885
Domain	THRAP3_BCLAF1	BCLAF1 THRAP3	2.15e-04	3	159	2	PF15440
Domain	DUF3496	ANKRD26 CCDC144A	2.15e-04	3	159	2	PF12001
Domain	Zinc_finger_PHD-type_CS	NSD3 PHF2 BPTF PHF20L1 KDM2A	2.30e-04	65	159	5	IPR019786
Domain	Znf_FYVE_PHD	PCLO NSD3 PHF2 BPTF PHF20L1 SYTL5 KDM2A	2.67e-04	147	159	7	IPR011011
Domain	TPR-contain_dom	RGPD2 RGPD1 ST13 P4HA1 RGPD3 ST13P5 DNAJC3	3.02e-04	150	159	7	IPR013026
Domain	TPR_REGION	RGPD2 RGPD1 ST13 P4HA1 RGPD3 ST13P5 DNAJC3	5.36e-04	165	159	7	PS50293
Domain	TPR	RGPD2 RGPD1 ST13 P4HA1 RGPD3 ST13P5 DNAJC3	5.36e-04	165	159	7	PS50005
Domain	TPR	RGPD2 RGPD1 ST13 RGPD3 ST13P5 DNAJC3	8.33e-04	129	159	6	SM00028
Domain	TPR-like_helical_dom	RGPD2 RGPD1 ST13 P4HA1 RGPD3 ST13P5 DNAJC3 SMG6	8.78e-04	233	159	8	IPR011990
Domain	Rho_GTPase_activation_prot	OCRL ARHGAP11A BCR SRGAP3 ARHGAP21	9.31e-04	88	159	5	IPR008936
Domain	TPR_repeat	RGPD2 RGPD1 ST13 P4HA1 RGPD3 DNAJC3	9.76e-04	133	159	6	IPR019734
Domain	Ricin_B_lectin	CRYBG1 CRYBG3 GALNT5	1.21e-03	25	159	3	PF00652
Domain	ZF_PHD_1	NSD3 PHF2 BPTF PHF20L1 KDM2A	1.38e-03	96	159	5	PS01359
Domain	RICIN	CRYBG1 CRYBG3 GALNT5	1.70e-03	28	159	3	SM00458
Domain	RICIN_B_LECTIN	CRYBG1 CRYBG3 GALNT5	1.70e-03	28	159	3	PS50231
Domain	-	RGPD2 RGPD1 ST13 P4HA1 RGPD3 DNAJC3 SMG6	2.00e-03	207	159	7	1.25.40.10
Domain	Ricin_B_lectin	CRYBG1 CRYBG3 GALNT5	2.08e-03	30	159	3	IPR000772
Domain	MIF4G	UPF2 EIF4G3	3.10e-03	10	159	2	SM00543
Domain	STI1	ST13 ST13P5	3.10e-03	10	159	2	SM00727
Domain	MIF4G	UPF2 EIF4G3	3.10e-03	10	159	2	PF02854
Domain	MIF4G-like_typ-3	UPF2 EIF4G3	3.10e-03	10	159	2	IPR003890
Domain	STI1_HS-bd	ST13 ST13P5	3.10e-03	10	159	2	IPR006636
Domain	ZF_CXXC	MBD1 KDM2A	3.77e-03	11	159	2	PS51058
Domain	Znf_CXXC	MBD1 KDM2A	3.77e-03	11	159	2	IPR002857
Domain	zf-CXXC	MBD1 KDM2A	3.77e-03	11	159	2	PF02008
Domain	-	HYOU1 HSPH1	4.49e-03	12	159	2	2.60.34.10
Domain	HSP70_peptide-bd	HYOU1 HSPH1	4.49e-03	12	159	2	IPR029047
Domain	Znf_PHD-finger	NSD3 PHF2 BPTF KDM2A	4.63e-03	79	159	4	IPR019787
Domain	IQ	IQCH SPA17 MYO3A CEP97	5.06e-03	81	159	4	SM00015
Domain	-	RNF169 RBBP6 PCLO PCGF5 NSD3 PHF2 BPTF PHF20L1 SYTL5 KDM2A	5.18e-03	449	159	10	3.30.40.10
Domain	-	HYOU1 HSPH1	5.28e-03	13	159	2	1.20.1270.10
Domain	Heat_shock_70_CS	HYOU1 HSPH1	5.28e-03	13	159	2	IPR018181
Domain	HSP70_C	HYOU1 HSPH1	5.28e-03	13	159	2	IPR029048
Domain	-	TCEA1 HDGFL2	5.28e-03	13	159	2	1.20.930.10
Domain	WH1	EVL PPP4R3A	5.28e-03	13	159	2	PS50229
Domain	C2	PCLO RAB11FIP1 BCR SYTL5 PLCB4	5.29e-03	131	159	5	PF00168
Domain	Znf_RING/FYVE/PHD	RNF169 RBBP6 PCLO PCGF5 NSD3 PHF2 BPTF PHF20L1 SYTL5 KDM2A	6.02e-03	459	159	10	IPR013083
Domain	TFIIS_N	TCEA1 HDGFL2	6.13e-03	14	159	2	IPR017923
Domain	C2	PCLO RAB11FIP1 BCR SYTL5 PLCB4	6.37e-03	137	159	5	SM00239
Domain	SET	NSD3 SETD5 PRDM15	7.03e-03	46	159	3	SM00317
Domain	Beta/gamma_crystallin	CRYBG1 CRYBG3	7.03e-03	15	159	2	IPR001064
Domain	-	UPF2 EIF4G3	7.03e-03	15	159	2	1.25.40.180
Domain	CRYSTALLIN_BETA_GAMMA	CRYBG1 CRYBG3	7.03e-03	15	159	2	PS50915
Domain	MIF4-like	UPF2 EIF4G3	7.03e-03	15	159	2	IPR016021
Domain	Crystall	CRYBG1 CRYBG3	7.03e-03	15	159	2	PF00030
Domain	XTALbg	CRYBG1 CRYBG3	7.03e-03	15	159	2	SM00247
Domain	PHD	NSD3 PHF2 BPTF KDM2A	7.05e-03	89	159	4	SM00249
Domain	TPR_1	RGPD1 ST13 ST13P5 DNAJC3	7.33e-03	90	159	4	IPR001440
Domain	TPR_1	RGPD1 ST13 ST13P5 DNAJC3	7.33e-03	90	159	4	PF00515
Domain	IQ_motif_EF-hand-BS	IQCH SPA17 MYO3A CEP97	7.33e-03	90	159	4	IPR000048
Domain	C2	PCLO RAB11FIP1 BCR SYTL5 PLCB4	7.39e-03	142	159	5	PS50004
Domain	Znf_PHD	NSD3 PHF2 BPTF KDM2A	7.62e-03	91	159	4	IPR001965
Domain	HSP70	HYOU1 HSPH1	7.99e-03	16	159	2	PF00012
Domain	IQ	IQCH SPA17 MYO3A CEP97	8.22e-03	93	159	4	PS50096
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	RGPD2 HSPH1 RGPD1 ST13 RGPD3 ST13P5	2.96e-05	73	116	6	MM14948
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 EVL RGPD2 LIMA1 AKAP5 HYOU1 ANK2 BCLAF1 SPEF2 PCLO HSPH1 RGPD1 ANKRD26 CCDC50 ERLEC1 PALB2 BPTF TLK1 PHF20L1 ZNF608 SETD5 STARD9 TNN RGPD3 BOD1L1 LIMCH1 EIF4G3 SPEN DNAJC3 HDGFL2 NIPBL THRAP3 ARHGAP21 TOP2B	5.29e-15	1442	163	34	35575683
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TLK2 TCEA1 FLII EVL RNF169 LIMA1 ZEB1 ATN1 RBBP6 BCLAF1 DAB2 RFC1 PALB2 PPP4R3A BPTF MYO3A TLK1 ZBTB40 AFDN LIMCH1 SPEN NIPBL THRAP3 TOP2B EPB41L2	3.44e-14	774	163	25	15302935
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TLK2 TCEA1 CUL1 EVL SETX HYOU1 BCLAF1 HSPH1 BCL7B CHD9 TSNAX RFC1 RSRC2 PALB2 PPP4R3A PHF2 BPTF TLK1 RESF1 RTRAF CIAPIN1 ZBTB40 NCOA1 QSER1 SPEN NIPBL THRAP3 TOP2B RBM17	4.70e-14	1103	163	29	34189442
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	LIMA1 SETX MAP2 MARK3 RANBP3 MBD1 ANKRD26 APC CEP192 RAB11FIP1 BCR NSD3 FSIP2 RESF1 CEP89 CLMN STARD9 CCSER2 PLEKHA5 AFDN BOD1L1 LIMCH1 CRYBG3 EIF4G3 ARHGAP21 EPB41L2	4.77e-14	861	163	26	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 FLII RGPD2 LIMA1 MIA3 ZEB1 ANK2 PDE1B BCLAF1 RGPD1 APC TRIOBP BCR KCNB1 SRGAP3 ATF7IP RGPD3 PLEKHA5 AFDN LIMCH1 QSER1 NIPBL THRAP3 ARHGAP21 AFF4 EPB41L2 SMG6	8.62e-14	963	163	27	28671696
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RNF169 SETX CHD9 RFC1 ARHGAP11A NSD3 PHF2 FSIP2 ORC2 BPTF PHF20L1 ZBTB40 KDM2A BOD1L1 TAF1 QSER1 SPEN PRDM15 HDGFL2 NIPBL TOP2B AFF4	1.41e-13	608	163	22	36089195
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LIMA1 ANK2 RBBP6 BCLAF1 RANBP3 HSPH1 ANKRD26 CCDC50 OCRL TSNAX RFC1 PPP4R3A ORC2 FAM193A CLMN ATF7IP CIAPIN1 BOD1L1 EIF4G3 HDGFL2 NIPBL ARHGAP21 TOP2B AFF4 EPB41L2 RBM17	3.07e-13	934	163	26	33916271
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	RBBP6 BCLAF1 RANBP3 NOL11 RFC1 ST13 PPP4R3A ORC2 BPTF BOD1L1 TAF1 SPEN HDGFL2 THRAP3 TOP2B AFF4	4.59e-13	283	163	16	30585729
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EVL MIA3 TUT4 ZBTB20 MAP2 MARK3 TRIOBP CHD9 CEP192 TSNAX BCR SHISA9 PHF2 BPTF CFAP20DC TLK1 ZNF608 SETD5 CLMN KYAT3 KDM2A BOD1L1 PLCB4 LIMCH1 QSER1 EIF4G3 PRDM15 DNAJC3 ICA1L THRAP3 AFF4 SMG6	4.63e-13	1489	163	32	28611215
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TLK2 TCEA1 FLII TUT4 HYOU1 CMTR1 BCLAF1 HSPH1 ANKRD26 APC TRIOBP NOL11 OCRL BCR FAM193A UPF2 CIAPIN1 KDM2A EIF4G3 SPEN THRAP3 TOP2B RBM17	5.60e-13	724	163	23	36232890
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD2 ZEB1 ZGRF1 RGPD1 APC BCR RBM20 PALB2 FAM193A RESF1 ZFHX4 ZNF608 ATF7IP RGPD3 PLEKHA5 TAF1 CRYBG3 ARHGAP21	1.51e-12	418	163	18	34709266
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TCEA1 RNF169 SETX RBBP6 BCLAF1 NOL11 CCDC50 RFC1 NSD3 PHF2 ORC2 BPTF ATF7IP RTRAF AFDN BOD1L1 TAF1 QSER1 SPEN HDGFL2 NIPBL THRAP3 TOP2B AFF4 RBM17	3.42e-12	954	163	25	36373674
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	FLII EVL RGPD2 MIA3 TUT4 ANK2 MAP2 BCLAF1 PCLO RGPD1 APC TRIOBP ATE1 BCR ST13 SHISA9 KCNB1 SRGAP3 RTRAF RGPD3 AFDN CRYBG3 EIF4G3 ST13P5 THRAP3 EPB41L2 RBM17	4.29e-12	1139	163	27	36417873
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MIA3 AKAP5 HYOU1 ANK2 MAP2 MARK3 BCLAF1 RANBP3 HSPH1 ANKRD26 TRIOBP NOL11 CEP192 SLC39A10 RAB11FIP1 TIMMDC1 ST13 FAM193A CEP89 P4HA1 CLMN CCSER2 PLEKHA5 CRYBG3 EIF4G3 DNAJC3 HDGFL2 TOP2B EPB41L2	6.84e-11	1487	163	29	33957083
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RNF169 SETX CEACAM5 RBBP6 MARK3 HSPH1 MBD1 APC TRIOBP NOL11 CCDC50 RSRC2 RAB11FIP1 NSD3 PHF2 SETD5 P4HA1 RTRAF RGPD3 CRYBG1 AFDN LIMCH1 EIF4G3 SPEN HDGFL2 NIPBL AFF4 EPB41L2 SMG6	8.01e-11	1497	163	29	31527615
Pubmed	Interaction network of human early embryonic transcription factors.	ZEB1 HYOU1 ATN1 BCL7B RGPD1 PCGF5 BPTF RESF1 ZFHX4 ZNF608 NCOA1 TAF1 QSER1 SPEN NIPBL	1.33e-10	351	163	15	38297188
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TRPM6 TLK2 CUL1 USP18 TUT4 CEACAM5 ZBTB20 MARK3 BCLAF1 APC PCGF5 PPM1B NSD3 TLK1 KCNB1 SETD5 KDM2A TAF1 GALNT5 THRAP3	2.76e-10	730	163	20	34857952
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLII RNF169 SETX RBBP6 BCLAF1 HSPH1 DAB2 APC RFC1 RAB11FIP1 PLEKHA5 AFDN EIF4G3 SPEN NIPBL THRAP3 EPB41L2	2.79e-10	503	163	17	16964243
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CUL1 SETX RBBP6 ZGRF1 ANKRD26 APC E2F7 CEP192 CNTLN BCR ST13 RBM20 PPP4R3A RESF1 ATF7IP CRYBG3 SPEN ZMYM6	3.97e-10	588	163	18	38580884
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CUL1 RNF169 SETX ZBTB20 RBBP6 BCLAF1 MBD1 NOL11 RFC1 ARHGAP11A PALB2 NSD3 PHF2 ORC2 BPTF ZNF276 TIGD2 RGPD3 KDM2A QSER1 SPEN HDGFL2 NIPBL THRAP3 TOP2B RBM17	4.01e-10	1294	163	26	30804502
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 TLK2 TCEA1 MIA3 SETX HYOU1 HSPH1 APC NOL11 CCDC50 CEP192 TSNAX SLC39A10 RESF1 SETD5 CLMN CCSER2 ZBTB40 CRYBG1 BOD1L1 QSER1 ARHGAP21 AFF4	1.64e-09	1084	163	23	11544199
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MIA3 RGPD1 DAB2 APC CEP192 BCR FAM193A PLEKHA5 CRYBG3 CEP97 ARHGAP21	4.89e-09	209	163	11	36779422
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	RGPD2 RANBP3 RGPD1 APC ST13 RGPD3 AFDN ST13P5 THRAP3 EPB41L2 RBM17	6.57e-09	215	163	11	35973513
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	FLII ZEB1 PCLO APC E2F7 RBM20 RESF1 ZFHX4 ZNF608 ATF7IP NCOA1 KDM2A TAF1 DNAJC3	6.79e-09	398	163	14	35016035
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	CMTR1 RBBP6 BCLAF1 RANBP3 ORC2 BPTF UPF2 KDM2A SPEN THRAP3 TOP2B AFF4 RBM17	9.28e-09	341	163	13	32971831
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	TCEA1 FLII RNF169 CMTR1 BCLAF1 ANKRD26 RFC1 RSRC2 ARHGAP11A PALB2 NSD3 PHF2 ZNF608 KDM2A SPEN PRDM15 THRAP3	1.15e-08	645	163	17	25281560
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TCEA1 CUL1 RNF169 RBBP6 BCLAF1 NOL11 CHD9 RFC1 PPP4R3A NSD3 BPTF CIAPIN1 KDM2A BOD1L1 TAF1 QSER1 HDGFL2 NIPBL THRAP3 TOP2B RBM17	1.36e-08	1014	163	21	32416067
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TUT4 ATN1 RBBP6 MBD1 BCL7B CHD9 RSRC2 RAB11FIP1 BCR NSD3 PHF2 BPTF ZNF469 RESF1 ZFHX4 ZNF608 SETD5 P4HA1 TAF1 CRYBG3 UNC80 AFF4	1.44e-08	1116	163	22	31753913
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLII EVL LIMA1 HYOU1 ANK2 MAP2 MARK3 BCLAF1 PCLO HSPH1 APC BCR ST13 UPF2 CLMN SRGAP3 RTRAF PLEKHA5 AFDN LIMCH1 EIF4G3 ST13P5 THRAP3 ARHGAP21 EPB41L2	1.48e-08	1431	163	25	37142655
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	LIMA1 RBBP6 BCLAF1 RANBP3 NSD3 BPTF CIAPIN1 PLEKHA5 AFDN KDM2A BOD1L1 TAF1 QSER1 SPEN THRAP3	5.49e-08	549	163	15	38280479
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD2 RGPD1 RGPD3 TOP2B	5.75e-08	9	163	4	18394993
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ATN1 RANBP3 BCL7B ORC2 ZNF608 NCOA1 TAF1 QSER1 NIPBL AFF4 RBM17	6.32e-08	268	163	11	33640491
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RNF169 MIA3 TUT4 HYOU1 APC CCDC50 SPA17 RSRC2 BCR ERLEC1 FAM193A P4HA1 CLMN CIAPIN1 PLEKHA5 BOD1L1 QSER1	7.31e-08	733	163	17	34672954
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	LIMA1 SETX BCLAF1 E2F7 PHF2 ZNF608 BOD1L1 NIPBL THRAP3 TOP2B RBM17	7.34e-08	272	163	11	31010829
Pubmed	A human MAP kinase interactome.	SETX RBBP6 DAB2 APC NCKAP5 ST13 PPP4R3A NSD3 TLK1 ATF7IP PLEKHA5 KDM2A TAF1 EPB41L2	8.15e-08	486	163	14	20936779
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	CUL1 LIMA1 MIA3 BCLAF1 ZGRF1 HSPH1 TSNAX ST13 PPP4R3A UPF2 RTRAF BOD1L1 EIF4G3 ST13P5 HDGFL2 NIPBL THRAP3 EPB41L2	1.09e-07	847	163	18	35235311
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TRIOBP PHF2 TLK1 ZNF608 SRGAP3 ZBTB40 PLEKHA5 KDM2A UNC80 SMG6	1.22e-07	225	163	10	12168954
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RGPD2 MAP2 BCLAF1 PCLO RGPD1 KCNB1 CLMN RGPD3 THRAP3 EPB41L2	1.56e-07	231	163	10	16452087
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	RGPD2 RGPD1 BPTF RGPD3 NIPBL THRAP3 TOP2B	1.72e-07	86	163	7	37253089
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	LIMA1 MIA3 SETX HYOU1 RBBP6 HSPH1 APC RFC1 RAB11FIP1 ERLEC1 NSD3 BPTF P4HA1 RTRAF KDM2A BOD1L1 PLCB4 ST13P5 DNAJC3 NIPBL EPB41L2 RBM17	1.97e-07	1297	163	22	33545068
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TLK2 RNF169 LIMA1 SETX CMTR1 CCDC50 TLK1 RESF1 ZNF608 RGPD3 CEP97 TOP2B EPB41L2	2.00e-07	444	163	13	34795231
Pubmed	Human transcription factor protein interaction networks.	LIMA1 ZEB1 ATN1 RBBP6 HSPH1 BCL7B RGPD1 CEP192 RFC1 PCGF5 RBM20 PHF2 BPTF RESF1 ZFHX4 ZNF608 ATF7IP ZBTB40 NCOA1 TAF1 QSER1 SPEN NIPBL	2.55e-07	1429	163	23	35140242
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HYOU1 ANK2 MARK3 BCLAF1 HSPH1 ANKRD26 APC OCRL ATE1 PLEKHA5 AFDN BOD1L1 CRYBG3 EIF4G3 ARHGAP21 EPB41L2	2.56e-07	708	163	16	39231216
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TLK2 CUL1 MARK3 BCLAF1 HSPH1 NOL11 CEP192 ANKRD36C BCR PCGF5 ANKRD36B FZR1 STK33 ANKRD36 HDGFL2 THRAP3 ARHGAP21 AFF4	3.11e-07	910	163	18	36736316
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	TCEA1 FLII SETX RBBP6 APC RFC1 PALB2 PHF2 BPTF KDM2A	3.24e-07	250	163	10	33536335
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	RBBP6 BCLAF1 BPTF RTRAF BOD1L1 SPEN HDGFL2 THRAP3 TOP2B RBM17	3.36e-07	251	163	10	31076518
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TCEA1 LIMA1 RBBP6 BCLAF1 FSIP2 RTRAF BOD1L1 QSER1 HDGFL2 THRAP3 EPB41L2 RBM17	4.51e-07	399	163	12	35987950
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CUL1 FLII SETX ANK2 MARK3 BCLAF1 HSPH1 BCL7B NOL11 RFC1 RSRC2 ANKRD36B PHF2 UPF2 P4HA1 STARD9 RTRAF LIMCH1 THRAP3 AFF4 EPB41L2 RBM17	5.02e-07	1371	163	22	36244648
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TUT4 RFC1 ORC2 BPTF P4HA1 AFDN TAF1 TOP2B RBM17	5.42e-07	203	163	9	22083510
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	CUL1 SETX CMTR1 MBD1 RSRC2 ORC2 BPTF ZFHX4 PHF20L1 P4HA1 ZBTB40 KDM2A QSER1 SPEN PRDM15 THRAP3 TOP2B	6.51e-07	857	163	17	25609649
Pubmed	Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.	RBBP6 HSPH1 NCKAP5 ST13 PPM1B BOD1L1 EIF4G3	7.21e-07	106	163	7	18654987
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SETX MAP2 RBBP6 BCLAF1 APC TRIOBP CHD9 RSRC2 NSD3 PHF2 BPTF UPF2 P4HA1 SPEN NIPBL THRAP3 TOP2B AFF4 RBM17	8.61e-07	1082	163	19	38697112
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SETX EFCAB6 BCLAF1 ANKRD26 APC CEP192 OCRL SLC39A10 ATF7IP STK33 AFDN EIF4G3 SPEN THRAP3 ARHGAP21 EPB41L2	8.71e-07	777	163	16	35844135
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	TUT4 RSRC2 ERLEC1 RBM20 AXDND1 TIGD2 PHF20L1 STARD9 STK33 NCOA1 KYAT3 PLCB4 CEP126 TDP1 ICA1L	9.29e-07	686	163	15	29987050
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	NSD3 BPTF BOD1L1	1.00e-06	5	163	3	26626481
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	PPM1B RESF1 LIMCH1 CRYBG3 UNC80 SPINK5	1.08e-06	71	163	6	33541421
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLII LIMA1 MIA3 BCLAF1 RANBP3 APC TRIOBP BPTF PLEKHA5 KDM2A NIPBL	1.18e-06	360	163	11	33111431
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	FLII RNF169 LIMA1 BCLAF1 APC TRIOBP STARD9 THRAP3 ARHGAP21 EPB41L2 RBM17	1.22e-06	361	163	11	30344098
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	LIMA1 MIA3 MARK3 ANKRD26 APC CEP192 RAB11FIP1 FAM193A CEP89 CCSER2 PLEKHA5 AFDN	1.45e-06	446	163	12	24255178
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	TLK2 FLII TUT4 ZEB1 MARK3 MBD1 DAB2 E2F7 CHD9 ARHGAP11A PPP4R3A FZR1 FAM193A LIMCH1 EIF4G3 THRAP3 EPB41L2	1.84e-06	925	163	17	28986522
Pubmed	GATA6 phosphorylation by Erk1/2 propels exit from pluripotency and commitment to primitive endoderm.	NANOGP8 NANOG DAB2	2.00e-06	6	163	3	29454706
Pubmed	Progression of the pluripotent epiblast depends upon the NMD factor UPF2.	NANOGP8 NANOG UPF2	2.00e-06	6	163	3	36255229
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TLK2 RGPD2 BCLAF1 BCL7B RGPD1 APC TRIOBP CEP192 ORC2 FZR1 TLK1 PHF20L1 RGPD3 CCSER2 NIPBL CEP97 THRAP3 TOP2B RBM17	2.24e-06	1155	163	19	20360068
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TCEA1 SETX RBBP6 RFC1 ORC2 BPTF CRYBG1 BOD1L1 SPEN HDGFL2 CEP97 TOP2B	2.43e-06	469	163	12	27634302
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MIA3 SETX HYOU1 ATN1 APC BCR RBM20 SMG8 UPF2 PLEKHA5 AFDN QSER1 CRYBG3 ARHGAP21	2.59e-06	650	163	14	38777146
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	MIA3 HYOU1 HSPH1 RGPD1 ANKRD26 APC CCDC50 CEP192 OCRL CNTLN ATE1 BCR CIAPIN1 AFDN CEP97 ARHGAP21	2.90e-06	853	163	16	28718761
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	FLII MIA3 TRIOBP BCR UPF2 CEP89 CCSER2 PLEKHA5 CEP97	3.13e-06	251	163	9	29778605
Pubmed	Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.	RGPD2 MAP2 RGPD1 RGPD3	3.18e-06	22	163	4	27717094
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	9037092
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	15710750
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	38657106
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	23818861
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	23536549
Pubmed	Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency.	NANOGP8 NANOG FZR1	3.49e-06	7	163	3	23077180
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD2 RGPD1 RGPD3	3.49e-06	7	163	3	20682751
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 CUL1 FLII HYOU1 BCLAF1 PCLO HSPH1 NOL11 RFC1 ST13 PHF2 STARD9 RTRAF AFDN BOD1L1 GALNT5 SPEN NIPBL THRAP3 TOP2B EPB41L2	3.56e-06	1425	163	21	30948266
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	FLII LIMA1 BCLAF1 HSPH1 MBD1 E2F7 RFC1 ORC2 ZFHX4 TAF1 THRAP3 EPB41L2 RBM17	4.12e-06	583	163	13	29844126
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CUL1 FLII MAP2 HSPH1 CHD9 P4HA1 PLEKHA5 PLCB4 LIMCH1 GALNT5 HDGFL2 ARHGAP21	4.39e-06	497	163	12	36774506
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MIA3 HYOU1 ANKRD26 APC FAM193A CCSER2 PLEKHA5 CRYBG3 ARHGAP21	4.58e-06	263	163	9	34702444
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	AKAP5 MARK3 ANKRD26 TRIOBP OCRL SLC39A10 RAB11FIP1 CEP89 PLEKHA5 ARHGAP21 EPB41L2	5.31e-06	421	163	11	36976175
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD2 RGPD1 RGPD3	5.56e-06	8	163	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD2 RGPD1 RGPD3	5.56e-06	8	163	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD2 RGPD1 RGPD3	5.56e-06	8	163	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD2 RGPD1 RGPD3	5.56e-06	8	163	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD2 RGPD1 RGPD3	5.56e-06	8	163	3	28745977
Pubmed	Genomic analysis of mouse retinal development.	CUL1 EVL RNF169 MAP2 MARK3 APC RFC1 ARHGAP11A PPP4R3A ZFHX4 SRGAP3 RTRAF NCOA1 MGARP HDGFL2 THRAP3 EPB41L2	5.59e-06	1006	163	17	15226823
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	MIA3 ZEB1 HYOU1 ATN1 RBBP6 PCLO CCDC50 ATF7IP CIAPIN1 HDGFL2 NIPBL	5.80e-06	425	163	11	24999758
Interaction	NUP43 interactions	SETX ATN1 RBBP6 BCLAF1 APC NOL11 CHD9 CCDC168 RFC1 NSD3 PHF2 FSIP2 BPTF RESF1 PHF20L1 ZNF608 ATF7IP CCSER2 KDM2A BOD1L1 EIF4G3 SPEN NIPBL TOP2B	1.85e-10	625	161	24	int:NUP43
Interaction	NAA40 interactions	LIMA1 ANK2 RBBP6 BCLAF1 RANBP3 HSPH1 ANKRD26 CCDC50 OCRL TSNAX RFC1 PPP4R3A ORC2 FAM193A CLMN ATF7IP CIAPIN1 BOD1L1 LIMCH1 EIF4G3 HDGFL2 NIPBL ARHGAP21 TOP2B AFF4 EPB41L2 RBM17	1.61e-08	978	161	27	int:NAA40
Interaction	H3C3 interactions	RNF169 SETX RFC1 ARHGAP11A NSD3 PHF2 FSIP2 ORC2 BPTF KDM2A BOD1L1 TAF1 QSER1 SPEN PRDM15 HDGFL2 NIPBL TOP2B AFF4	1.71e-08	495	161	19	int:H3C3
Interaction	H2BC8 interactions	RNF169 ZEB1 CMTR1 NOL11 RFC1 RSRC2 ARHGAP11A PALB2 NSD3 PHF2 ORC2 BPTF KDM2A QSER1 TDP1 SPEN PRDM15 HDGFL2 NIPBL TOP2B	3.69e-08	576	161	20	int:H2BC8
Interaction	CEBPA interactions	TLK2 TCEA1 CUL1 EVL SETX HYOU1 BCLAF1 HSPH1 BCL7B CHD9 TSNAX RFC1 RSRC2 PALB2 PPP4R3A PHF2 BPTF TLK1 RESF1 RTRAF CIAPIN1 ZBTB40 NCOA1 QSER1 SPEN HDGFL2 NIPBL THRAP3 TOP2B RBM17	4.91e-08	1245	161	30	int:CEBPA
Interaction	YWHAH interactions	CCDC125 LIMA1 SETX MAP2 MARK3 RANBP3 HSPH1 ANKRD26 APC CEP192 RAB11FIP1 BCR NSD3 FZR1 RESF1 CEP89 CLMN STARD9 CCSER2 NCOA1 PLEKHA5 AFDN BOD1L1 LIMCH1 CRYBG3 EIF4G3 ARHGAP21 EPB41L2	4.92e-08	1102	161	28	int:YWHAH
Interaction	H3-3A interactions	RNF169 NANOG CHD9 RFC1 ARHGAP11A NSD3 PHF2 ORC2 BPTF PHF20L1 ZBTB40 KDM2A BOD1L1 TAF1 QSER1 SPEN PRDM15 HDGFL2 NIPBL THRAP3 TOP2B AFF4	1.39e-07	749	161	22	int:H3-3A
Interaction	PFN1 interactions	FLII EVL ANK2 PCLO ANKRD26 APC CEP192 OCRL BCR FZR1 PLEKHA5 AFDN BOD1L1 LIMCH1 CRYBG3 CEP97 ARHGAP21 AFF4	1.42e-07	509	161	18	int:PFN1
Interaction	MEN1 interactions	CUL1 ATN1 CMTR1 RBBP6 BCLAF1 RANBP3 NANOG NOL11 RFC1 NSD3 ORC2 BPTF PHF20L1 ZNF608 UPF2 RTRAF AFDN KDM2A BOD1L1 TAF1 QSER1 SPEN THRAP3 TOP2B AFF4 RBM17	1.77e-07	1029	161	26	int:MEN1
Interaction	SNRNP40 interactions	TLK2 TCEA1 SETX ATN1 RBBP6 BCLAF1 NOL11 RFC1 RBM20 NSD3 FZR1 TLK1 PHF20L1 ZNF608 KDM2A SPEN HDGFL2 TOP2B EPB41L2 RBM17	1.88e-07	637	161	20	int:SNRNP40
Interaction	SMC5 interactions	TCEA1 RNF169 SETX RBBP6 BCLAF1 NOL11 CCDC50 RFC1 NSD3 PHF2 ORC2 BPTF ATF7IP RTRAF AFDN BOD1L1 TAF1 QSER1 SPEN HDGFL2 NIPBL THRAP3 TOP2B AFF4 RBM17	3.83e-07	1000	161	25	int:SMC5
Interaction	TERF2IP interactions	ZEB1 SETX CMTR1 RBBP6 BCL7B NOL11 RFC1 RSRC2 NSD3 BPTF ZNF608 ATF7IP BOD1L1 TAF1 QSER1 SPEN NIPBL AFF4	4.68e-07	552	161	18	int:TERF2IP
Interaction	SFN interactions	CCDC125 LIMA1 MAP2 MARK3 RANBP3 HSPH1 ANKRD26 APC CEP192 RAB11FIP1 ARHGAP11A BCR ST13 CEP89 CLMN CCSER2 PLEKHA5 CRYBG3 ARHGAP21 EPB41L2	6.95e-07	692	161	20	int:SFN
Interaction	ASF1A interactions	TLK2 CUL1 RNF169 CMTR1 ST13 NSD3 PHF2 TLK1 TAF1 QSER1 SPEN ZMYM6	7.95e-07	249	161	12	int:ASF1A
Interaction	APEX1 interactions	TLK2 FLII RNF169 TUT4 ZEB1 CMTR1 MARK3 MBD1 DAB2 E2F7 NOL11 CHD9 RFC1 ARHGAP11A PPP4R3A NSD3 PHF2 BPTF FZR1 FAM193A LIMCH1 EIF4G3 HDGFL2 NIPBL THRAP3 TOP2B AFF4 EPB41L2	9.03e-07	1271	161	28	int:APEX1
Interaction	GSK3A interactions	MIA3 MAP2 MARK3 BCLAF1 RGPD1 DAB2 APC CEP192 BCR FAM193A CRYBG1 PLEKHA5 CRYBG3 CEP97 THRAP3 ARHGAP21	1.02e-06	464	161	16	int:GSK3A
Interaction	FLOT1 interactions	LIMA1 AKAP5 ANK2 MARK3 PCLO ANKRD26 APC SLC34A2 SLC39A10 RAB11FIP1 CEP89 PLEKHA5 BOD1L1 CRYBG3 ARHGAP21 EPB41L2	1.39e-06	475	161	16	int:FLOT1
Interaction	KCNA3 interactions	HYOU1 CMTR1 ANK2 RBBP6 MARK3 BCLAF1 SPEF2 HSPH1 ANKRD26 APC CHD9 OCRL ATE1 RSRC2 PLEKHA5 AFDN BOD1L1 CRYBG3 EIF4G3 SPEN ARHGAP21 EPB41L2	1.75e-06	871	161	22	int:KCNA3
Interaction	POLR1G interactions	CUL1 RNF169 CMTR1 NOL11 CHD9 RFC1 RSRC2 NSD3 PHF2 BPTF ATF7IP KDM2A TAF1 NIPBL TOP2B AFF4	2.02e-06	489	161	16	int:POLR1G
Interaction	YWHAG interactions	LIMA1 MAP2 MARK3 BCLAF1 RANBP3 HSPH1 MBD1 ANKRD26 APC CEP192 CNTLN RAB11FIP1 BCR ST13 FZR1 CEP89 CLMN STARD9 CCSER2 PLEKHA5 AFDN BOD1L1 EIF4G3 CEP97 THRAP3 ARHGAP21 EPB41L2	2.05e-06	1248	161	27	int:YWHAG
Interaction	FXR1 interactions	CUL1 EVL MIA3 TUT4 ATN1 CMTR1 BCLAF1 NANOG TRIOBP OCRL TSNAX ORC2 FZR1 UPF2 CEP89 AFDN CEP126 THRAP3 SMG6	2.17e-06	679	161	19	int:FXR1
Interaction	SYNE3 interactions	MIA3 HYOU1 ANKRD26 APC CEP192 OCRL PALB2 FAM193A P4HA1 CLMN CCSER2 CRYBG3 DNAJC3 CEP97 ARHGAP21	2.90e-06	444	161	15	int:SYNE3
Interaction	LYN interactions	EVL LIMA1 AKAP5 ANK2 MARK3 ANKRD26 APC TSNAX SLC39A10 RAB11FIP1 PHF2 CEP89 PLEKHA5 AFDN CEP97 THRAP3 ARHGAP21 TOP2B EPB41L2	5.07e-06	720	161	19	int:LYN
Interaction	YWHAZ interactions	CCDC125 TLK2 CUL1 EVL LIMA1 PDE1B MAP2 MARK3 ANKRD26 APC NOL11 CEP192 RAB11FIP1 BCR PCGF5 FSIP2 FZR1 MYO3A CEP89 SRGAP3 STARD9 CCSER2 PLEKHA5 AFDN CEP126 ARHGAP21 EPB41L2	5.76e-06	1319	161	27	int:YWHAZ
Interaction	SAMD4B interactions	NANOG APC CEP192 RSRC2 BCR FAM193A CEP89 CCSER2	6.21e-06	122	161	8	int:SAMD4B
Interaction	SOX2 interactions	FLII LIMA1 ZEB1 MARK3 BCLAF1 NANOG BCL7B ANKRD26 TRIOBP NOL11 CHD9 CNTLN RFC1 BPTF FZR1 ZFHX4 PHF20L1 ZNF608 P4HA1 BOD1L1 QSER1 EIF4G3 SPEN NIPBL THRAP3 ARHGAP21 SMG6 SPINK5	7.82e-06	1422	161	28	int:SOX2
Interaction	PAX6 interactions	TLK2 ZEB1 RANBP3 BCL7B PCGF5 BPTF TLK1 ZFHX4 ZNF608 TAF1 QSER1 NIPBL EPB41L2	8.02e-06	366	161	13	int:PAX6
Interaction	TEAD2 interactions	ZBTB20 NANOG RFC1 NSD3 ORC2 FZR1 ZFHX4 NCOA1	9.92e-06	130	161	8	int:TEAD2
Interaction	OCLN interactions	MIA3 AKAP5 ANK2 MARK3 ANKRD26 APC OCRL SLC39A10 RAB11FIP1 CEP89 CCSER2 PLEKHA5 AFDN ARHGAP21 EPB41L2	1.21e-05	500	161	15	int:OCLN
Interaction	VAV2 interactions	RBBP6 HSPH1 NCKAP5 ST13 PPM1B BOD1L1 EIF4G3	1.47e-05	99	161	7	int:VAV2
Interaction	XRCC6 interactions	ZEB1 HYOU1 CMTR1 RBBP6 BCLAF1 RANBP3 NOL11 RFC1 ST13 PPP4R3A PHF2 ORC2 BPTF FZR1 BOD1L1 TAF1 SPEN HDGFL2 THRAP3 TOP2B AFF4	1.64e-05	928	161	21	int:XRCC6
Interaction	GOLGA1 interactions	RGPD1 ANKRD26 APC CEP192 CLMN CCSER2 CRYBG3 TDP1 CEP97	1.68e-05	183	161	9	int:GOLGA1
Interaction	CBX3 interactions	TLK2 CUL1 RNF169 ZEB1 RBBP6 NANOG CHD9 RFC1 PCGF5 NSD3 ORC2 ATF7IP KDM2A SPEN HDGFL2 NIPBL TOP2B	1.70e-05	646	161	17	int:CBX3
Interaction	FGFR4 interactions	HYOU1 DAB2 ANKRD26 APC TRIOBP CEP192 OCRL SLC39A10 RAB11FIP1 NCR3LG1 NSD3 FZR1 EDAR PLEKHA5	1.94e-05	458	161	14	int:FGFR4
Interaction	CCND1 interactions	CUL1 FLII HSPH1 APC E2F7 RFC1 FZR1 NCOA1 KDM2A LIMCH1 TAF1	1.97e-05	286	161	11	int:CCND1
Interaction	CBX1 interactions	NANOG ATE1 ST13 NSD3 ATF7IP KDM2A HDGFL2 NIPBL THRAP3 TOP2B EPB41L2	2.10e-05	288	161	11	int:CBX1
Interaction	HNF1B interactions	ZEB1 BCLAF1 BPTF ZFHX4 ZNF608 ATF7IP QSER1 NIPBL THRAP3	2.27e-05	190	161	9	int:HNF1B
Interaction	HDAC1 interactions	FLII ZEB1 EFCAB6 ZGRF1 NANOG HSPH1 APC RFC1 BCR RBM20 PALB2 PPP4R3A BPTF FZR1 ZFHX4 PHF20L1 ZNF608 PLEKHA5 TAF1 CRYBG3 SPEN ARHGAP21 TOP2B	2.48e-05	1108	161	23	int:HDAC1
Interaction	CSNK2A3 interactions	BCLAF1 ANKRD36C PCGF5 ANKRD36B ANKRD36 HDGFL2 THRAP3	2.91e-05	110	161	7	int:CSNK2A3
Interaction	SP7 interactions	CUL1 ATN1 RBBP6 BCL7B PCGF5 RBM20 ZFHX4 ZNF608 NCOA1 QSER1 NIPBL	3.44e-05	304	161	11	int:SP7
Interaction	H3C1 interactions	TLK2 RNF169 AKAP5 ANK2 RFC1 ARHGAP11A PALB2 NSD3 ORC2 BPTF TLK1 KDM2A TAF1 SPEN DNAJC3 HDGFL2 NIPBL THRAP3 TOP2B AFF4	3.49e-05	901	161	20	int:H3C1
Interaction	TBXT interactions	ATN1 BCL7B ZFHX4 ZNF608 QSER1 SPEN NIPBL	4.10e-05	116	161	7	int:TBXT
Interaction	RCOR1 interactions	FLII ZGRF1 APC BCR RBM20 PALB2 PPP4R3A FAM193A RESF1 ZFHX4 PLEKHA5 TAF1 SPEN ARHGAP21	4.43e-05	494	161	14	int:RCOR1
Interaction	PARP1 interactions	CUL1 FLII RNF169 ZEB1 HYOU1 CMTR1 MARK3 NANOG MBD1 NOL11 RFC1 PPM1B NSD3 PHF2 BPTF FZR1 STARD9 KDM2A TDP1 HDGFL2 NIPBL THRAP3 TOP2B AFF4 EPB41L2	4.64e-05	1316	161	25	int:PARP1
Interaction	KRT8 interactions	MIA3 ANKRD26 APC CEP192 FZR1 FAM193A CEP89 CCSER2 CRYBG1 PLEKHA5 CRYBG3 CEP97 ARHGAP21	5.62e-05	441	161	13	int:KRT8
Interaction	EGR2 interactions	ATN1 PCGF5 RESF1 ZFHX4 ZNF608 NCOA1 QSER1 NIPBL	7.12e-05	171	161	8	int:EGR2
Interaction	RAD18 interactions	LIMA1 RBBP6 BCLAF1 ORC2 BPTF SRGAP3 RTRAF SPEN HDGFL2 THRAP3 TOP2B EPB41L2 RBM17	8.05e-05	457	161	13	int:RAD18
Interaction	BRSK2 interactions	MAP2 HSPH1 BCR FZR1 SRGAP3 EIF4G3	9.01e-05	91	161	6	int:BRSK2
Interaction	KLF3 interactions	ZEB1 HYOU1 PCGF5 BPTF ZNF608 ATF7IP TAF1 QSER1 NIPBL	9.34e-05	228	161	9	int:KLF3
Interaction	OTUD7A interactions	FLII ANK2 RSRC2 KCNB1 AFDN	9.96e-05	58	161	5	int:OTUD7A
Interaction	MAPRE3 interactions	CEP104 MAP2 MARK3 APC NCKAP5 BCR CCSER2 PLEKHA5 ARHGAP21	9.99e-05	230	161	9	int:MAPRE3
Interaction	PHF21A interactions	ZGRF1 APC BCR RBM20 FAM193A RESF1 ZFHX4 PLEKHA5 TAF1 CRYBG3 ARHGAP21	1.02e-04	343	161	11	int:PHF21A
Interaction	NFKBIL1 interactions	NAP1L3 NOL11 CHD9 SPEN HDGFL2 AFF4	1.02e-04	93	161	6	int:NFKBIL1
Interaction	SPATA1 interactions	TLK2 CMTR1 TLK1 SMG6	1.04e-04	31	161	4	int:SPATA1
Interaction	SPAST interactions	CUL1 ANK2 MAP2 PCLO APC AFDN THRAP3	1.12e-04	136	161	7	int:SPAST
Interaction	KCTD13 interactions	FLII EVL LIMA1 HYOU1 ANK2 MAP2 MARK3 BCLAF1 PCLO HSPH1 APC BCR ST13 UPF2 CLMN SRGAP3 RTRAF PLEKHA5 AFDN LIMCH1 EIF4G3 CEP97 THRAP3 ARHGAP21 EPB41L2	1.16e-04	1394	161	25	int:KCTD13
Interaction	AR interactions	TCEA1 FLII ATN1 EFCAB6 RANBP3 BCL7B RAB11FIP1 ORC2 FZR1 ZNF608 RTRAF NCOA1 LIMCH1 TAF1 QSER1 NIPBL THRAP3 TOP2B AFF4 RBM17	1.30e-04	992	161	20	int:AR
Interaction	DDX23 interactions	CMTR1 RBBP6 BCLAF1 NOL11 RSRC2 PPP4R3A PHF2 TAF1 HDGFL2 THRAP3 TOP2B AFF4 RBM17	1.31e-04	480	161	13	int:DDX23
Interaction	CEP128 interactions	ANKRD26 APC CEP192 OCRL TSNAX BCR CEP89 CCSER2 CEP97 ARHGAP21	1.42e-04	297	161	10	int:CEP128
Interaction	H2BC21 interactions	CUL1 RNF169 BCLAF1 PCLO RFC1 PALB2 NSD3 PHF2 ORC2 BPTF TNN CRYBG1 KDM2A QSER1 NIPBL TOP2B	1.49e-04	696	161	16	int:H2BC21
Interaction	SENP3 interactions	CUL1 SETX ZBTB20 NANOG RFC1 P4HA1 ATF7IP AFDN TAF1 TOP2B	1.59e-04	301	161	10	int:SENP3
Interaction	CNTRL interactions	HYOU1 ANKRD26 CEP192 ST13 CEP89 ST13P5 DNAJC3 ARHGAP21	1.65e-04	193	161	8	int:CNTRL
Interaction	YAP1 interactions	LIMA1 ZEB1 HYOU1 ATN1 MAP2 RBBP6 BCLAF1 RANBP3 HSPH1 TRIOBP TSNAX NSD3 BPTF CIAPIN1 AFDN KDM2A BOD1L1 TAF1 SPEN THRAP3 EPB41L2	1.75e-04	1095	161	21	int:YAP1
Interaction	CAPZA2 interactions	FLII LIMA1 RBBP6 NANOG DAB2 TRIOBP ARHGAP11A FZR1 CRYBG1 AFDN LIMCH1 ARHGAP21	1.82e-04	430	161	12	int:CAPZA2
Interaction	KDM1A interactions	FLII ZEB1 ZGRF1 NANOG APC BCR RBM20 PALB2 FAM193A RESF1 ZFHX4 PHF20L1 ZNF608 SRGAP3 ATF7IP PLEKHA5 TAF1 CRYBG3 ARHGAP21	1.91e-04	941	161	19	int:KDM1A
Interaction	CRX interactions	ATN1 BCL7B PCGF5 ZFHX4 ZNF608 NCOA1 QSER1 SPEN NIPBL	2.11e-04	254	161	9	int:CRX
Interaction	CENPA interactions	RNF169 MBD1 RFC1 NSD3 PHF2 BPTF KDM2A TAF1 HDGFL2 NIPBL TOP2B	2.31e-04	377	161	11	int:CENPA
Interaction	FEV interactions	ZEB1 BCL7B PCGF5 ZFHX4 ZNF608 TAF1 QSER1 NIPBL	2.33e-04	203	161	8	int:FEV
Interaction	PLK4 interactions	FLII HSPH1 APC CEP192 ARHGAP11A PPM1B CCSER2	2.42e-04	154	161	7	int:PLK4
Interaction	ASF1B interactions	TLK2 TSNAX ST13 FZR1 TLK1 TAF1	2.43e-04	109	161	6	int:ASF1B
Interaction	ZNF330 interactions	RNF169 NOL11 RFC1 NSD3 PHF2 ORC2 KDM2A TAF1 PRDM15 NIPBL TOP2B AFF4	2.54e-04	446	161	12	int:ZNF330
Interaction	EN1 interactions	ZEB1 NAP1L3 ZFHX4 ZNF608 QSER1 NIPBL	2.56e-04	110	161	6	int:EN1
Interaction	STX6 interactions	MIA3 MARK3 DAB2 ANKRD26 OCRL SLC39A10 RAB11FIP1 TIMMDC1 PLEKHA5 CRYBG3 ARHGAP21 EPB41L2	2.64e-04	448	161	12	int:STX6
Interaction	DIRAS3 interactions	MARK3 ANKRD26 APC SLC39A10 PALB2 CEP89 PLEKHA5 ARHGAP21 EPB41L2	2.65e-04	262	161	9	int:DIRAS3
Interaction	DHX9 interactions	CUL1 FLII USP18 ZEB1 CMTR1 MAP2 NANOG OCRL ST13 NSD3 FZR1 RTRAF NIPBL THRAP3 RBM17	2.81e-04	662	161	15	int:DHX9
Interaction	PPP1CC interactions	CUL1 FLII RNF169 LIMA1 BCLAF1 APC TRIOBP RAB11FIP1 CLMN STARD9 CEP126 THRAP3 ARHGAP21 EPB41L2 SMG6 RBM17	2.88e-04	738	161	16	int:PPP1CC
Interaction	THOC1 interactions	CMTR1 RBBP6 BCLAF1 OCRL ARHGAP11A RTRAF SPEN THRAP3	2.92e-04	210	161	8	int:THOC1
Interaction	SASS6 interactions	NANOG RGPD1 ANKRD26 APC CEP192 FZR1 CEP97	2.94e-04	159	161	7	int:SASS6
Interaction	DNAJB5 interactions	HYOU1 ANK2 HSPH1 CCSER2 TAF1 DNAJC3	3.10e-04	114	161	6	int:DNAJB5
Interaction	WDR82 interactions	SETX NANOG OCRL ARHGAP11A BCR FZR1 PLEKHA5 BOD1L1	3.22e-04	213	161	8	int:WDR82
Interaction	ZYX interactions	EVL ANK2 APC CEP192 CLMN PLEKHA5 LIMCH1 CRYBG3 CEP97 ARHGAP21	3.23e-04	329	161	10	int:ZYX
Interaction	USP37 interactions	CUL1 PHF2 FZR1 TAF1 SPEN NIPBL	3.25e-04	115	161	6	int:USP37
Interaction	CEP135 interactions	MIA3 ANKRD26 APC CEP192 CNTLN BCR CCSER2 CEP97 ARHGAP21	3.49e-04	272	161	9	int:CEP135
Interaction	AFDN interactions	LIMA1 MARK3 ANKRD26 APC CEP192 BCR CEP89 PLEKHA5 AFDN ARHGAP21	3.56e-04	333	161	10	int:AFDN
Interaction	UTRN interactions	LIMA1 MARK3 HSPH1 BCR ST13 P4HA1 AFDN EIF4G3	3.64e-04	217	161	8	int:UTRN
Interaction	CAMKV interactions	BCLAF1 CHD9 SPEN THRAP3 AFF4 EPB41L2	3.73e-04	118	161	6	int:CAMKV
Interaction	DUXB interactions	BPTF RESF1 ZFHX4	3.74e-04	18	161	3	int:DUXB
Interaction	CT45A5 interactions	NAP1L3 CHD9 PPP4R3A SPEN AFF4	4.03e-04	78	161	5	int:CT45A5
Interaction	RHOB interactions	AKAP5 MARK3 DAB2 ANKRD26 TRIOBP OCRL SLC39A10 RAB11FIP1 ARHGAP11A BCR CEP89 PLEKHA5 AFDN PLCB4 ARHGAP21 TOP2B EPB41L2	4.10e-04	840	161	17	int:RHOB
Interaction	NUP50 interactions	RNF169 ZEB1 RBBP6 BCL7B NOL11 RFC1 NSD3 BOD1L1 TAF1 SPEN	4.29e-04	341	161	10	int:NUP50
Interaction	ERG interactions	BCL7B RESF1 ZFHX4 ZNF608 ATF7IP QSER1 NIPBL TOP2B	4.37e-04	223	161	8	int:ERG
Interaction	SUPT5H interactions	TCEA1 SETX CMTR1 BCLAF1 RANBP3 PPP4R3A PHF2 SETD5 SPEN NIPBL THRAP3	4.52e-04	408	161	11	int:SUPT5H
Interaction	FEZ2 interactions	TLK2 TSNAX PPM1B RTRAF	4.53e-04	45	161	4	int:FEZ2
Interaction	CTNNA1 interactions	MARK3 HSPH1 ANKRD26 APC BCR CLMN PLEKHA5 AFDN ARHGAP21 EPB41L2	4.91e-04	347	161	10	int:CTNNA1
Interaction	NFIX interactions	ZEB1 BPTF ZFHX4 ZNF608 ZBTB40 QSER1 SPEN NIPBL	4.91e-04	227	161	8	int:NFIX
Interaction	RFC2 interactions	CUL1 FLII NANOG RFC1 FZR1 RTRAF LIMCH1	5.07e-04	174	161	7	int:RFC2
Interaction	ZDHHC15 interactions	PPM1B RESF1 LIMCH1 CRYBG3 UNC80 SPINK5	5.08e-04	125	161	6	int:ZDHHC15
Interaction	SOX7 interactions	RBM20 RESF1 ZFHX4 ZNF608 NCOA1	5.08e-04	82	161	5	int:SOX7
Interaction	EZR interactions	LIMA1 ANK2 MARK3 HSPH1 ANKRD26 APC TRIOBP OCRL BCR PLEKHA5 LIMCH1 EIF4G3 ARHGAP21	5.13e-04	553	161	13	int:EZR
Interaction	RGPD3 interactions	RGPD2 RGPD1 TSNAX RGPD3	5.36e-04	47	161	4	int:RGPD3
GeneFamily	Beta-gamma crystallin domain containing	CRYBG1 CRYBG3	9.98e-05	3	105	2	1360
GeneFamily	PHD finger proteins	NSD3 PHF2 BPTF PHF20L1 KDM2A	1.78e-04	90	105	5	88
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD2 RGPD1 ST13 RGPD3 DNAJC3	5.55e-04	115	105	5	769
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PCLO RAB11FIP1 BCR	1.18e-03	36	105	3	823
GeneFamily	UPF1 like RNA helicases	SETX ZGRF1	1.78e-03	11	105	2	1169
GeneFamily	Zinc fingers CXXC-type	MBD1 KDM2A	2.12e-03	12	105	2	136
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP11A SRGAP3 ARHGAP21	3.06e-03	50	105	3	721
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 ZFHX4	3.34e-03	15	105	2	529
GeneFamily	Heat shock 70kDa proteins	HYOU1 HSPH1	4.29e-03	17	105	2	583
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA1 TAF1	4.29e-03	17	105	2	486
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	TCEA1 LIMA1 TUT4 SETX BCLAF1 HSPH1 NAP1L3 APC CEP192 RFC1 RSRC2 ARHGAP11A BPTF RESF1 PHF20L1 ATF7IP QSER1 DNAJC3 NIPBL TOP2B RBM17	7.96e-10	656	162	21	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TLK2 CUL1 TUT4 ZEB1 SETX ZBTB20 MARK3 APC CHD9 ARHGAP11A PPM1B ORC2 BPTF TLK1 FAM193A UPF2 CCSER2 NCOA1 PLCB4 CRYBG3 EIF4G3 SPEN NIPBL	3.35e-09	856	162	23	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	EVL TUT4 ZEB1 SETX RBBP6 MARK3 BCLAF1 SPEF2 EVI2B RSRC2 PCGF5 PPM1B PPP4R3A BPTF TLK1 ZNF276 RESF1 PHF20L1 SETD5 SRGAP3 ATF7IP CCSER2 NCOA1 CRYBG1 KDM2A BOD1L1 SPEN NIPBL THRAP3 TOP2B	9.51e-09	1492	162	30	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TLK2 CUL1 TUT4 MARK3 CHD9 PPM1B ORC2 BPTF TLK1 UPF2 CCSER2 NCOA1 LIMCH1 EIF4G3 SPEN	2.24e-07	466	162	15	M13522
Coexpression	GSE369_IFNG_KO_VS_WT_LIVER_UP	RNF169 TUT4 PDE1B MBD1 BCR RESF1 CEP89 SRGAP3 NIPBL CEP97	4.82e-07	199	162	10	M5970
Coexpression	AIZARANI_LIVER_C20_LSECS_3	LIMA1 ZEB1 RBBP6 DAB2 CCDC50 ADM LYVE1 LIMCH1 AFF4 CCDC144A RBM17	2.42e-06	295	162	11	M39121
Coexpression	GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	HSPH1 NAP1L3 SLC39A10 ORC2 TLK1 KDM2A QSER1 AFF4 CCDC144A	3.53e-06	194	162	9	M4687
Coexpression	MURARO_PANCREAS_BETA_CELL	TCEA1 MIA3 MAP2 PCLO HSPH1 MBD1 APC CHD9 RAB11FIP1 PCGF5 ST13 ADM MYO3A CCSER2 PLCB4 EIF4G3 DNAJC3 UNC80 AFF4	6.60e-06	946	162	19	M39169
Coexpression	GABRIELY_MIR21_TARGETS	ZBTB20 APC TSNAX PHF20L1 CRYBG1 LIMCH1 TAF1 NIPBL CEP97 ARHGAP21	1.35e-05	289	162	10	M2196
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP	BCLAF1 CHD9 PPM1B PPP4R3A UPF2 NIPBL TOP2B	1.45e-05	127	162	7	M40905
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	CEP104 TUT4 ZEB1 BPTF SRGAP3 ATF7IP ZBTB40 KDM2A	1.70e-05	180	162	8	M8239
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MIA3 TUT4 ANK2 PDE1B MAP2 PCLO NAP1L3 APC OCRL NCR3LG1 ANKRD36B FSIP2 ZFHX4 SRGAP3 BOD1L1 PLCB4 ANKRD36 CEP126 ICA1L CCDC144A	1.72e-05	1106	162	20	M39071
Coexpression	AIZARANI_LIVER_C9_LSECS_1	LIMA1 ZEB1 TRIOBP CCDC50 ADM LYVE1 LIMCH1 EIF4G3 AFF4 EPB41L2	2.08e-05	304	162	10	M39113
Coexpression	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN	TLK2 EVL SETX ZBTB20 ATN1 ATF7IP ZBTB40 NIPBL	3.49e-05	199	162	8	M9253
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	MIA3 BCLAF1 MBD1 SLC39A10 RSRC2 ST13 PPM1B PHF20L1 ATF7IP CCSER2 ST13P5 THRAP3 EPB41L2	3.51e-05	543	162	13	MM997
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN	EVL TUT4 MARK3 CHD9 CEP192 ATE1 RFC1 CRYBG1	3.62e-05	200	162	8	M9842
Coexpression	GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN	FLII CHD9 EVI2B CNTLN ATF7IP NCOA1 PLCB4 SMG6	3.62e-05	200	162	8	M7502
Coexpression	GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	NAP1L3 SLC34A2 NCKAP5 RBM20 PPM1B STARD9 RTRAF KYAT3	3.62e-05	200	162	8	M7905
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	LIMA1 BCLAF1 TRIOBP CHD9 SLC39A10 ST13 PPP4R3A TLK1 TAF1 ST13P5 THRAP3 SMG6	5.06e-05	484	162	12	MM999
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ZBTB20 ANK2 PCLO ANKRD26 CHD9 NCKAP5 PLEKHA5 AFDN	7.31e-05	221	162	8	M39222
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	TRPM6 FLII RBBP6 TRIOBP CNTLN PHF20L1 SRGAP3	7.76e-05	165	162	7	M8121
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	ZEB1 RBBP6 BCLAF1 BCL7B NAP1L3 RFC1 BCR PPM1B PPP4R3A PHF20L1 NCOA1 BOD1L1 EIF4G3 AFF4	8.87e-05	680	162	14	M41089
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	MIA3 BCLAF1 MBD1 SLC39A10 RSRC2 ST13 PPM1B PHF20L1 ATF7IP CCSER2 THRAP3 EPB41L2	9.81e-05	519	162	12	M3395
Coexpression	FISCHER_DREAM_TARGETS	TCEA1 RBBP6 BCLAF1 ZGRF1 E2F7 CEP192 RFC1 ARHGAP11A PALB2 ORC2 FZR1 ATF7IP CRYBG1 TDP1 NIPBL CEP97 THRAP3	1.10e-04	969	162	17	M149
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	TLK2 TCEA1 ZEB1 BCLAF1 APC ATE1 ST13 ORC2 TIGD2 RTRAF ST13P5 NIPBL	1.28e-04	534	162	12	MM1054
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES	HYOU1 PDE1B ATE1 RFC1 EIF4G3	1.40e-04	80	162	5	MM17502
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN	ZFP3 HSPH1 CCDC50 EVI2B TSNAX RESF1 NCOA1 KYAT3	1.41e-04	243	162	8	M41178
Coexpression	ULE_SPLICING_VIA_NOVA2	BPTF PLCB4 ARHGAP21 EPB41L2	1.44e-04	43	162	4	M1551
Coexpression	ULE_SPLICING_VIA_NOVA2	BPTF PLCB4 ARHGAP21 EPB41L2	1.44e-04	43	162	4	MM666
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	LIMA1 BCLAF1 TRIOBP CHD9 SLC39A10 ST13 PPP4R3A TLK1 TAF1 THRAP3 SMG6	1.64e-04	467	162	11	M1347
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	MARK3 HSPH1 RSRC2 RAB11FIP1 AREG RESF1 UPF2 SETD5 ATF7IP CCSER2 ZBTB40 NCOA1 KDM2A NIPBL AFF4	1.87e-04	822	162	15	M6782
Coexpression	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	CEACAM5 APC CRYBG1 ARHGAP21 TOP2B	2.08e-04	87	162	5	MM851
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	IQCH E2F7 PPP4R3A FSIP2 ZNF276 KDM2A PLCB4	2.25e-04	196	162	7	M6129
Coexpression	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	AKAP5 ZBTB20 IQCH EFCAB6 ZFP3 PCLO BCL7B TRIOBP EDAR SRGAP3	2.33e-04	407	162	10	M2214
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP	MARK3 ANKRD26 ZBTB40 CEP126 TDP1 EIF4G3 DNAJC3	2.40e-04	198	162	7	M9934
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	LIMA1 NOL11 CCDC168 BCR ORC2 CIAPIN1 PRDM15	2.40e-04	198	162	7	M4293
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	ZEB1 ZGRF1 RANBP3 ANKRD26 E2F7 TRIOBP CEP192 CNTLN ANKRD36C ARHGAP11A ANKRD36B FZR1 ANKRD36 TDP1 HDGFL2 EPB41L2	2.46e-04	939	162	16	M45768
Coexpression	HALLMARK_MITOTIC_SPINDLE	APC CEP192 RFC1 BCR PCGF5 TLK1 EPB41L2	2.47e-04	199	162	7	M5893
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN	CUL1 ZEB1 RBBP6 BCLAF1 NOL11 CCDC50 RSRC2 RAB11FIP1 PCGF5 AREG PPM1B PPP4R3A NCOA1 KDM2A DNAJC3	2.48e-04	844	162	15	M41129
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	TUT4 CHD9 RFC1 ZNF608 CEP97 TOP2B EPB41L2	2.55e-04	200	162	7	M8090
Coexpression	GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP	TRPM6 ZEB1 HSPH1 TIGD2 SETD5 MGARP ICA1L	2.55e-04	200	162	7	M9301
Coexpression	GSE8835_CD4_VS_CD8_TCELL_UP	CUL1 SPEF2 CNTLN PALB2 TAF1 THRAP3 SMG6	2.55e-04	200	162	7	M6254
Coexpression	GSE30083_SP1_VS_SP3_THYMOCYTE_DN	USP18 ANKRD26 E2F7 AXDND1 PHF20L1 ICA1L CEP97	2.55e-04	200	162	7	M5026
Coexpression	GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN	HYOU1 HSPH1 APC ST13 AREG ADM CIAPIN1	2.55e-04	200	162	7	M4386
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	TLK2 CUL1 TUT4 CHD9 ORC2 TLK1	2.91e-04	145	162	6	M1810
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	BCLAF1 APC BPTF	3.27e-04	22	162	3	M14523
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	BCLAF1 APC BPTF	3.27e-04	22	162	3	MM676
Coexpression	SHEN_SMARCA2_TARGETS_UP	SETX BCLAF1 APC TSNAX RSRC2 ST13 TLK1 UPF2 NCOA1 LIMCH1	3.53e-04	429	162	10	M29
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	TLK2 TUT4 ZEB1 SETX ANK2 PDE1B RBBP6 MARK3 BCLAF1 ZGRF1 HSPH1 ANKRD26 APC E2F7 CCDC50 CHD9 CEP192 CNTLN SPA17 RFC1 RSRC2 PALB2 ORC2 BPTF FAM193A UPF2 SETD5 BOD1L1 QSER1 CEP126 NIPBL THRAP3 ARHGAP21 RBM17	5.61e-11	1257	160	34	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	TLK2 TUT4 ZEB1 SETX ANK2 PDE1B MAP2 RBBP6 MARK3 BCLAF1 ZGRF1 HSPH1 ANKRD26 APC E2F7 CCDC50 CHD9 CEP192 CNTLN SPA17 RFC1 RSRC2 PALB2 ORC2 BPTF FAM193A UPF2 SETD5 BOD1L1 QSER1 CEP126 NIPBL THRAP3 ARHGAP21 RBM17	7.11e-10	1459	160	35	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	TLK2 LIMA1 TUT4 ZEB1 SETX MAP2 BCLAF1 HSPH1 ANKRD26 APC CHD9 CEP192 CNTLN SPA17 SLC39A10 RFC1 PPP4R3A NSD3 ORC2 SMG8 RESF1 SETD5 KYAT3 BOD1L1 QSER1 CEP126 NIPBL THRAP3 TOP2B	5.69e-08	1252	160	29	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TLK2 TUT4 ZEB1 SETX ANK2 PDE1B BCLAF1 HSPH1 ANKRD26 APC E2F7 CCDC50 CHD9 NCKAP5 CEP192 CNTLN SPA17 SETD5 SRGAP3 BOD1L1 PLCB4 QSER1 CEP126 NIPBL CEP97 THRAP3	1.01e-07	1060	160	26	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	TLK2 TCEA1 ZEB1 ZBTB20 CMTR1 ZGRF1 HSPH1 APC CHD9 CNTLN BPTF SMG8 CFAP20DC UPF2 SETD5 BOD1L1 TAF1 QSER1 NIPBL	2.91e-07	629	160	19	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TLK2 TUT4 ZEB1 ZBTB20 ANK2 ZFP3 MAP2 BCLAF1 HSPH1 ANKRD26 APC E2F7 TRIOBP CHD9 ZC3H12B RFC1 PCGF5 BPTF TLK1 SETD5 SRGAP3 BOD1L1 PLCB4 CEP126 NIPBL CEP97 THRAP3 ARHGAP21 TOP2B	3.80e-07	1370	160	29	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	TLK2 SETX EFCAB6 BCLAF1 HSPH1 APC E2F7 CEP192 SLC39A10 RSRC2 MYO3A PHF20L1 UPF2 CEP126 NIPBL RBM17	5.48e-07	469	160	16	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TLK2 TCEA1 ZEB1 CMTR1 ZGRF1 PCLO APC CCDC50 CHD9 NCKAP5 BPTF SMG8 CFAP20DC UPF2 SETD5 KDM2A BOD1L1 TAF1	5.97e-07	595	160	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	TLK2 CUL1 LIMA1 TUT4 ZEB1 SETX BCLAF1 HSPH1 ANKRD26 APC CHD9 CEP192 CNTLN RSRC2 PALB2 ORC2 RESF1 SETD5 KYAT3 BOD1L1 QSER1 CEP126 NIPBL THRAP3 TOP2B RBM17	2.02e-06	1241	160	26	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TLK2 TUT4 ZEB1 SETX ANK2 PDE1B MAP2 BCLAF1 HSPH1 ANKRD26 APC E2F7 CCDC50 CHD9 NCKAP5 CEP192 CNTLN SPA17 ADM SETD5 SRGAP3 BOD1L1 PLCB4 QSER1 CEP126 NIPBL CEP97 THRAP3	2.31e-06	1414	160	28	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	TLK2 FLII EVL ZBTB20 ATN1 RBBP6 PCLO HSPH1 ANKRD26 NCKAP5 OCRL ERLEC1 FAM193A CEP89 CCSER2 BOD1L1 NIPBL ARHGAP21 TOP2B AFF4	4.65e-06	831	160	20	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	SETX BCLAF1 PCLO HSPH1 ANKRD26 E2F7 CEP192 RSRC2 PALB2 PPP4R3A PHF20L1 CEP126 NIPBL THRAP3 RBM17	1.26e-05	532	160	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	TLK2 TCEA1 ZEB1 CMTR1 MARK3 ZGRF1 HSPH1 APC CCDC50 CHD9 BPTF SMG8 UPF2 SETD5 QSER1	2.49e-05	564	160	15	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	TLK2 CUL1 LIMA1 TUT4 ZEB1 SETX BCLAF1 HSPH1 ANKRD26 APC CHD9 CEP192 CNTLN RSRC2 PALB2 ORC2 RESF1 SETD5 KYAT3 BOD1L1 QSER1 CEP126 NIPBL THRAP3 TOP2B RBM17	3.89e-05	1468	160	26	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	TUT4 SETX APC CCDC50 OCRL RFC1 TLK1 RESF1 PLEKHA5 LIMCH1 DNAJC3	5.47e-05	339	160	11	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	TLK2 TCEA1 LIMA1 TUT4 CMTR1 APC CNTLN ZNF276 ZFHX4 BOD1L1 QSER1 NIPBL	1.11e-04	432	160	12	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	TLK2 TUT4 ZBTB20 BCLAF1 DAB2 CHD9 OCRL RSRC2 ERLEC1 NSD3 TLK1 RESF1 CLMN STARD9 GALNT5 THRAP3 EPB41L2	1.19e-04	801	160	17	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	TLK2 TUT4 ZBTB20 RBBP6 ANKRD26 FAM193A BOD1L1 NIPBL ARHGAP21 TOP2B	1.29e-04	311	160	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	TLK2 TCEA1 LIMA1 TUT4 ZBTB20 CMTR1 EFCAB6 MAP2 PCLO HSPH1 APC CNTLN ZNF276 ZFHX4 BOD1L1 LIMCH1 TAF1 QSER1 NIPBL	1.71e-04	989	160	19	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500	AKAP5 MAP2 CNTLN SRGAP3	2.30e-04	40	160	4	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	LIMA1 TUT4 SETX EFCAB6 CCDC50 CNTLN LIMCH1 CEP126 NIPBL	4.44e-04	298	160	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP104 SETX RBBP6 BCLAF1 HSPH1 MBD1 ANKRD26 ERLEC1 ANKRD36B BPTF RESF1 BOD1L1 ANKRD36 CEP126 NIPBL	7.98e-16	199	161	15	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	LIMA1 SETX BCLAF1 HSPH1 MBD1 ANKRD26 RFC1 ADM BPTF RTRAF BOD1L1 LIMCH1 DNAJC3 NIPBL	1.97e-14	199	161	14	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	LIMA1 RBBP6 BCLAF1 HSPH1 MBD1 ANKRD26 RFC1 NSD3 ADM BPTF BOD1L1 LIMCH1 NIPBL	4.49e-13	199	161	13	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TCEA1 LIMA1 BCLAF1 PCLO MBD1 RFC1 NSD3 BPTF BOD1L1 ANKRD36 LIMCH1 NIPBL	9.39e-12	199	161	12	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 USP18 SETX BCLAF1 RSRC2 BPTF RESF1 ATF7IP KDM2A BOD1L1 NIPBL AFF4	9.96e-12	200	161	12	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 SETX BCLAF1 APC CCDC50 CHD9 ZNF608 EIF4G3 NIPBL THRAP3 TOP2B	7.75e-11	184	161	11	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	TUT4 ZBTB20 ANK2 MAP2 BCLAF1 CHD9 ANKRD36C BPTF ZNF608 ANKRD36 TOP2B	1.70e-10	198	161	11	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	LIMA1 BCLAF1 ERLEC1 NSD3 BPTF CCSER2 CRYBG1 BOD1L1 EIF4G3 DNAJC3 NIPBL	1.79e-10	199	161	11	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP104 SETX RBBP6 BCLAF1 HSPH1 MBD1 ANKRD26 BPTF BOD1L1 DNAJC3 NIPBL	1.79e-10	199	161	11	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TUT4 ZEB1 SETX SPEF2 NCKAP5 BPTF RESF1 ZNF608 AFDN PLCB4 NIPBL	1.89e-10	200	161	11	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	RGPD2 TUT4 ZEB1 BCLAF1 HSPH1 CCDC50 RSRC2 PPP4R3A CRYBG1 KDM2A	2.09e-09	191	161	10	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ZEB1 RBBP6 ANKRD26 CNTLN ANKRD36C RSRC2 UPF2 BOD1L1 ANKRD36 SMG6	2.82e-09	197	161	10	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TUT4 ZEB1 SETX SPEF2 NCKAP5 ADM BPTF ZNF608 AFDN PLCB4	3.26e-09	200	161	10	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	TUT4 RBBP6 BCLAF1 RSRC2 BPTF NCOA1 BOD1L1 SPEN NIPBL EPB41L2	3.26e-09	200	161	10	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	RBBP6 BCLAF1 RSRC2 AREG BPTF RESF1 KDM2A BOD1L1 NIPBL AFF4	3.26e-09	200	161	10	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SETX RBBP6 APC RESF1 EDAR UPF2 CCSER2 BOD1L1 TAF1	2.70e-08	186	161	9	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ZBTB20 BCLAF1 HSPH1 ANKRD36C ATF7IP ANKRD36 SPEN NIPBL SMG6	2.96e-08	188	161	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERICH3 SPEF2 CCDC190 ZNF608 CLMN SRGAP3 PLEKHA5 CEP126 ICA1L	3.71e-08	193	161	9	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	ANK2 MAP2 PCLO APC SHISA9 NCOA1 LIMCH1 CEP126 CCDC144A	4.83e-08	199	161	9	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	ANK2 MAP2 PCLO APC SHISA9 NCOA1 LIMCH1 CEP126 CCDC144A	4.83e-08	199	161	9	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	TUT4 ZEB1 SETX SPEF2 NCKAP5 BPTF ZNF608 AFDN PLCB4	5.04e-08	200	161	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TUT4 ZEB1 SETX SPEF2 NCKAP5 BPTF ZNF608 AFDN PLCB4	5.04e-08	200	161	9	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	MIA3 RESF1 ZNF608 SRGAP3 ATF7IP AFDN KDM2A THRAP3	1.69e-07	166	161	8	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB20 CHD9 RBM20 P4HA1 ATF7IP THRAP3 ARHGAP21 TOP2B	2.64e-07	176	161	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 HSPH1 BPTF SETD5 PLEKHA5 AFDN NIPBL AFF4	5.31e-07	193	161	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	USP18 TUT4 BCLAF1 RSRC2 PPP4R3A NSD3 ANKRD36B CRYBG1	5.31e-07	193	161	8	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 AREG ADM FSIP2 SYTL5 CLMN TBX10 GALNT5	5.53e-07	194	161	8	49cc5f5de4380302100e8cd937f08abe317ac75e
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-goblet\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM5 AREG ADM FSIP2 SYTL5 CLMN TBX10 GALNT5	5.53e-07	194	161	8	fb935df966c451e659b8bde281f8aebcb632f6cf
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ERICH3 SPEF2 SLC34A2 STK33 PLEKHA5 PLCB4 LIMCH1 CEP126	5.74e-07	195	161	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ERICH3 SPEF2 SLC34A2 STK33 PLEKHA5 PLCB4 LIMCH1 CEP126	5.74e-07	195	161	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 ZEB1 ZBTB20 ANKRD36C ATF7IP CCSER2 CRYBG1 ANKRD36	5.74e-07	195	161	8	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TUT4 ANKRD26 ANKRD36C SLC39A10 ANKRD36B BPTF RESF1 ANKRD36	5.74e-07	195	161	8	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIA3 CEACAM5 AREG ADM SYTL5 CLMN TBX10 GALNT5	5.97e-07	196	161	8	c2d17630f7bfc9e727de55e093c17fddac61b61f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP2 PCLO SHISA9 ANKRD36B KCNB1 PLEKHA5 ANKRD36 UNC80	5.97e-07	196	161	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	ZEB1 ZBTB20 CHD9 ZFHX4 ZNF608 PLCB4 QSER1 ARHGAP21	5.97e-07	196	161	8	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	ZEB1 ZBTB20 CHD9 ZFHX4 ZNF608 PLCB4 QSER1 ARHGAP21	5.97e-07	196	161	8	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIA3 CEACAM5 AREG ADM SYTL5 CLMN TBX10 GALNT5	5.97e-07	196	161	8	54c30023d04e7265373647f56fc93885804938b0
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	ERICH3 SPEF2 SLC34A2 SRGAP3 STK33 PLEKHA5 LIMCH1 CEP126	5.97e-07	196	161	8	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 IQCH EFCAB6 SPEF2 ANKRD26 KCNB1 STK33 CEP126	6.20e-07	197	161	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	RBBP6 NCKAP5 CCDC168 ATF7IP ZBTB40 SPEN RBM17	6.22e-07	135	161	7	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CUL1 RBBP6 BCLAF1 ANKRD26 BPTF TLK1 BOD1L1 NIPBL	6.45e-07	198	161	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SETX BCLAF1 HSPH1 AREG BPTF BOD1L1 LIMCH1 NIPBL	6.70e-07	199	161	8	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	EVL LIMA1 ZBTB20 MAP2 APC ANKRD36C BOD1L1 ANKRD36	6.70e-07	199	161	8	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	USP18 EVL TUT4 ZEB1 ANKRD36C NSD3 ANKRD36B RESF1	6.70e-07	199	161	8	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	TUT4 ZEB1 ANKRD36C ANKRD36B RESF1 ATF7IP ANKRD36	1.32e-06	151	161	7	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	EVL ARHGAP11A NSD3 RESF1 CCSER2 AFDN ANKRD36	3.02e-06	171	161	7	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TUT4 HSPH1 ANKRD36C ATF7IP CRYBG1 ANKRD36 CCDC144A	3.02e-06	171	161	7	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	ZGRF1 E2F7 CNTLN ARHGAP11A ZNF608 PLEKHA5 ARHGAP21	3.26e-06	173	161	7	67f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	NAP1L3 ANKRD26 BCR KCNB1 UPF2 CCSER2 RBM17	3.79e-06	177	161	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPH1 ANKRD36C RAB11FIP1 ANKRD36B SRGAP3 ARHGAP21 AFF4	4.08e-06	179	161	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CCDC50 CHD9 ZNF608 EIF4G3 NIPBL TOP2B	4.56e-06	182	161	7	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CCDC50 CHD9 RSRC2 ZNF608 TOP2B AFF4	4.56e-06	182	161	7	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	MAP2 HSPH1 SLC34A2 NCKAP5 RAB11FIP1 STK33 LIMCH1	4.72e-06	183	161	7	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	CHD9 ANKRD36C PPP4R3A NSD3 ANKRD36B BPTF AFDN	5.07e-06	185	161	7	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CCDC50 CHD9 ZNF608 EIF4G3 NIPBL TOP2B	5.07e-06	185	161	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZEB1 MAP2 NCKAP5 STARD9 PLCB4 LIMCH1 UNC80	5.44e-06	187	161	7	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	(1)_T_cells-(1)_T_CD4_fh\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	EVL LIMA1 CCDC50 EVI2B TLK1 RESF1 CRYBG1	6.04e-06	190	161	7	120ca702600373c208a3d032fede0a040736e5cf
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ANK2 NCKAP5 RBM20 STK33 PLEKHA5 LIMCH1 ADPRHL1	6.04e-06	190	161	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 SPEF2 CCDC190 E2F7 SPA17 CFAP20DC CEP126	6.25e-06	191	161	7	683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 IQCH EFCAB6 SPEF2 CCDC190 STK33 CEP126	6.25e-06	191	161	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 IQCH EFCAB6 SPEF2 CCDC190 STK33 CEP126	6.25e-06	191	161	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 IQCH EFCAB6 SPEF2 CCDC190 STK33 CEP126	6.25e-06	191	161	7	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 HSPH1 BPTF PLEKHA5 AFDN NIPBL AFF4	6.47e-06	192	161	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 PCLO RAB11FIP1 ADM LYVE1 ZFHX4 EPB41L2	6.47e-06	192	161	7	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 SPEF2 CCDC190 SPA17 CLMN STK33 CEP126	7.16e-06	195	161	7	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ERICH3 SPEF2 STK33 PLEKHA5 PLCB4 LIMCH1 CEP126	7.16e-06	195	161	7	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 PCLO KCNB1 NCOA1 BOD1L1 UNC80 AFF4	7.16e-06	195	161	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 SPEF2 CCDC190 SPA17 CLMN STK33 CEP126	7.16e-06	195	161	7	6365e3893e38231090ec2dbef010dec71dea3d07
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 SPEF2 CCDC190 SPA17 CLMN STK33 CEP126	7.16e-06	195	161	7	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERICH3 SPEF2 CCDC190 SPA17 CLMN STK33 CEP126	7.65e-06	197	161	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	USP18 TUT4 BCLAF1 RSRC2 NSD3 KDM2A BOD1L1	7.65e-06	197	161	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	USP18 TUT4 BCLAF1 RSRC2 NSD3 KDM2A BOD1L1	7.91e-06	198	161	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	mLN-B_cell-B_cell_memory\|B_cell / Region, Cell class and subclass	TCEA1 ZBTB20 HSPH1 CCDC50 RAB11FIP1 AREG UPF2	7.91e-06	198	161	7	e2c63ca9f82f8524447e398b11a676b22d2f58ce
ToppCell	PSB\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERICH3 HSPH1 SLC34A2 ZNF608 STK33 PLCB4 LIMCH1	7.91e-06	198	161	7	4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP18 TUT4 BCLAF1 RSRC2 NSD3 KDM2A BOD1L1	7.91e-06	198	161	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 ZBTB20 ANKRD36C BPTF ATF7IP ANKRD36 SMG6	8.17e-06	199	161	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	ASK452-Epithelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	ERICH3 HSPH1 SLC34A2 SPA17 RAB11FIP1 AFDN LIMCH1	8.17e-06	199	161	7	e8778d4d2bc7e15b4c7989a93e5808a76738df46
ToppCell	mild-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CUL1 CCDC50 NCKAP5 SRGAP3 LIMCH1 CRYBG3 EPB41L2	8.45e-06	200	161	7	86f585bf9066b179bbcbc703bf43f15da4a07284
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MAP2 PCLO ANKRD36B KCNB1 PLEKHA5 ANKRD36 UNC80	8.45e-06	200	161	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CEACAM5 MAP2 SLC34A2 NCKAP5 RAB11FIP1 LIMCH1 GALNT5	8.45e-06	200	161	7	c6f211bbadd0c9be776c58807249e06764df47dc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal\|3m / Sample Type, Dataset, Time_group, and Cell type.	SPEF2 DAB2 SPA17 RAB11FIP1 P4HA1 GALNT5 DNAJC3	8.45e-06	200	161	7	ce012d738cbec1afdd6af0e10e94b2b6c17b036e
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CEACAM5 MAP2 SLC34A2 NCKAP5 RAB11FIP1 LIMCH1 GALNT5	8.45e-06	200	161	7	5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67
ToppCell	mild-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP18 ZEB1 ZBTB20 ANKRD26 ST13 RESF1 CCSER2	8.45e-06	200	161	7	c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CEACAM5 MAP2 SLC34A2 NCKAP5 RAB11FIP1 LIMCH1 GALNT5	8.45e-06	200	161	7	e3a80626941363bfc9d97ef906d38c97080aecb1
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC50 ZC3H12B SHISA9 FSIP2 KCNB1 CEP97	2.15e-05	155	161	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	FLU-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	USP18 AKAP5 ZFP3 RFC1 CFAP20DC SRGAP3	2.48e-05	159	161	6	97c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCell	FLU-Healthy-1\|FLU / Virus stimulation, Condition and Cluster	USP18 AKAP5 ZFP3 RFC1 CFAP20DC SRGAP3	2.48e-05	159	161	6	fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCell	CD8+_Memory_T_cell-FLU-1\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	ZFP3 RFC1 ADM CFAP20DC P4HA1 SRGAP3	2.76e-05	162	161	6	76f39935763848ea6e7917b2f9f1432c543063d9
ToppCell	LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EVL AKAP5 EVI2B AREG SHISA9 ICA1L	3.16e-05	166	161	6	3b750d4023a0a09d86113aae5a97d84391f7b482
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 MAP2 PCLO NCKAP5 LIMCH1 GALNT5	3.50e-05	169	161	6	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 MAP2 NCKAP5 RAB11FIP1 EDAR LIMCH1	3.99e-05	173	161	6	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC34A2 ZNF608 STK33 PLEKHA5 LIMCH1 GALNT5	3.99e-05	173	161	6	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EVL ANK2 ZGRF1 CEP192 SLC39A10 ZNF469	4.12e-05	174	161	6	9bb8159a62640756d18ecbade3bf32bcbb7dd590
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EVL ANK2 ZGRF1 CEP192 SLC39A10 ZNF469	4.12e-05	174	161	6	e70cc623a3a6aceec813ed852fec0c4240561133
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EVL ANK2 ZGRF1 CEP192 SLC39A10 ZNF469	4.12e-05	174	161	6	b6725086fe5a2b057c7c495ec63c970ac52c2580
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZEB1 NCKAP5 CLMN STARD9 PLCB4 EPB41L2	4.67e-05	178	161	6	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 SPEF2 CCDC190 CLMN STK33 CEP126	4.67e-05	178	161	6	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MAP2 SLC34A2 NCKAP5 RAB11FIP1 STK33 LIMCH1	4.82e-05	179	161	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 ADM SRGAP3 STK33 CRYBG1 LIMCH1	4.97e-05	180	161	6	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	severe-CD8+_T_naive\|severe / disease stage, cell group and cell class	ZGRF1 SPEF2 ANKRD26 ORC2 EDAR NCOA1	4.97e-05	180	161	6	94fe530367b170777f4051a4034cff06d80dbb83
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	ZEB1 SETX MARK3 DAB2 APC CHD9 PPM1B TLK1 SETD5 ZBTB40 NIPBL	6.21e-08	180	160	11	4541_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	ZEB1 CHD9 CEP192 BPTF ZFHX4 ATF7IP CCSER2 NCOA1 PLEKHA5 NIPBL	3.79e-07	171	160	10	7535_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	OCRL PPM1B CLMN NCOA1 TBX10 TAF1 EIF4G3 NIPBL SPINK5	8.64e-06	191	160	9	6022_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	RANBP3 ANKRD26 ADM FZR1 ZNF276 CLMN ZBTB40 TAF1 CEP97	9.39e-06	193	160	9	5024_DN
Drug	Thimerosal	LIMA1 MIA3 SETX ANK2 BCLAF1 PCLO APC CHD9 RFC1 ADM FSIP2 PHF20L1 CEP89 P4HA1 ATF7IP PLEKHA5 BOD1L1 PLCB4 CEP126 SPEN NIPBL THRAP3 AFF4	1.14e-05	1199	160	23	ctd:D013849
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	RANBP3 ANKRD26 APC TLK1 ZFHX4 NCOA1 LIMCH1 EPB41L2 SPINK5	1.15e-05	198	160	9	5246_DN
Drug	Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A	AKAP5 ZEB1 CEACAM5 MAP2 EVI2B FZR1 EDAR TBX10 AFDN	1.20e-05	199	160	9	5384_UP
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ZEB1 RSRC2 PPP4R3A ADM ATF7IP AFDN DNAJC3 AFF4	2.25e-05	165	160	8	3851_UP
Drug	1w4q	TCEA1 BCLAF1 TAF1	2.77e-05	9	160	3	CID005289534
Disease	colon cancer (implicated_via_orthology)	NANOGP8 NANOG APC	2.45e-05	11	159	3	DOID:219 (implicated_via_orthology)
Disease	white matter microstructure measurement	NCKAP5 PPP4R3A BPTF AXDND1 ZNF276 SRGAP3 EIF4G3 DNAJC3 ICA1L ARHGAP21	5.40e-05	390	159	10	EFO_0005674
Disease	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy	SETX TDP1	8.63e-05	3	159	2	cv:C1846574
Disease	C-reactive protein measurement	ZEB1 BCL7B CCDC168 CEP192 ST13 BPTF TLK1 ZNF469 ZNF276 ZNF608 SETD5 ZBTB40 QSER1 EIF4G3 ARHGAP21 TOP2B AFF4	2.89e-04	1206	159	17	EFO_0004458
Disease	N6-methyllysine measurement	PCGF5 CEP89	5.95e-04	7	159	2	EFO_0800061
Disease	Cornelia De Lange Syndrome	SETD5 NIPBL	7.91e-04	8	159	2	C0270972
Disease	5-HIAA measurement	AFDN THRAP3 SMG6	1.22e-03	39	159	3	EFO_0005132
Disease	age at onset, multiple sclerosis	NCKAP5 AXDND1	1.26e-03	10	159	2	EFO_0004847, MONDO_0005301
Disease	white matter hyperintensity measurement	EVL ANK2 SPEF2 PPP4R3A KCNB1 LIMCH1 PRDM15	1.30e-03	302	159	7	EFO_0005665
Disease	mean reticulocyte volume	MARK3 MBD1 RFC1 PPP4R3A ZNF469 RESF1 PHF20L1 ATF7IP ZBTB40 AFDN ARHGAP21 EPB41L2	1.36e-03	799	159	12	EFO_0010701
Disease	triacylglycerol 56:2 measurement	ZFHX4 LIMCH1	1.54e-03	11	159	2	EFO_0010429
Disease	Neurodevelopmental Disorders	ANK2 PHF2 SETD5 SRGAP3	1.63e-03	93	159	4	C1535926
Disease	alcohol and nicotine codependence	RGPD2 RGPD1	2.16e-03	13	159	2	EFO_0004776
Disease	response to methotrexate, aspartate aminotransferase measurement	MAP2 NOL11	2.52e-03	14	159	2	EFO_0004736, GO_0031427
Disease	Germ Cell Cancer	NANOG ATF7IP	2.89e-03	15	159	2	C0740345
Disease	Embryonal Neoplasm	NANOG ATF7IP	2.89e-03	15	159	2	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	NANOG ATF7IP	2.89e-03	15	159	2	C0027658
Disease	Germ cell tumor	NANOG ATF7IP	2.89e-03	15	159	2	C0205851
Disease	Neoplasms, Embryonal and Mixed	NANOG ATF7IP	2.89e-03	15	159	2	C0205852
Disease	Cancer, Embryonal	NANOG ATF7IP	2.89e-03	15	159	2	C0751364
Disease	Cancer, Embryonal and Mixed	NANOG ATF7IP	2.89e-03	15	159	2	C0751365
Disease	Intellectual Disability	TLK2 ATN1 APC BPTF SRGAP3 ZBTB40 TAF1 ZMYM6	3.03e-03	447	159	8	C3714756
Disease	Nasal Cavity Polyp	MIA3 SPEF2 NCOA1	3.28e-03	55	159	3	EFO_1000391
Disease	sleep apnea measurement	E2F7 CFAP20DC LIMCH1 ZMYM6	3.64e-03	116	159	4	EFO_0007817
Disease	response to efavirenz, virologic response measurement	HYOU1 MBD1 SHISA9	3.81e-03	58	159	3	EFO_0006904, EFO_0006906
Disease	neuroticism measurement, wellbeing measurement, depressive symptom measurement	SHISA9 EIF4G3	4.65e-03	19	159	2	EFO_0007006, EFO_0007660, EFO_0007869
Disease	alpha-tocopherol measurement	CFAP20DC STK33	5.14e-03	20	159	2	EFO_0007898

Protein segments in the cluster

Peptide	Gene	Start	Entry
DAKEKRSKSQDADSP	AFDN	1766	P55196
KQQDVQTPSAKEEEK	ADAM29	706	Q9UKF5
KESAKAQLSSPEDQD	SMG6	991	Q86US8
DNLDPEKESETSSQK	ERICH3	536	Q5RHP9
EAEEKEKSNEIPTKN	ERLEC1	166	Q96DZ1
PQNKTESENTSDKPK	AREG	111	P15514
TAKAANSKSKESDEP	CCDC50	241	Q8IVM0
SQKISPTEDGKDQKE	CNTLN	891	Q9NXG0
KDQKESDPTEDSQTQ	CNTLN	901	Q9NXG0
KDDQDKTEKDLQNPS	CRYBG3	146	Q68DQ2
SNKDAKDPTTKNSLE	BCR	626	P11274
SSNNSKPVEDKDAVA	CEACAM5	506	P06731
SEETNAPKKTKTEQE	ATN1	81	P54259
KEPVETAVDNNSKVK	CIAPIN1	96	Q6FI81
SSQKQPAEKATSDDK	ANKRD36	546	A6QL64
SQKQPAEKATSDEKD	ANKRD36	581	A6QL64
SQKQPALKATTDEKD	ANKRD36	751	A6QL64
SPQKQRAEKATSDDK	ANKRD36B	256	Q8N2N9
SQKQPAEKATSDEKD	ANKRD36B	291	Q8N2N9
SDDEDLNFDTKNVPK	ANKRD26	261	Q9UPS8
KSPEETEKDKNETEN	BPTF	571	Q12830
EKEKSKSNSSAAREP	BCL7B	56	Q9BQE9
DDFKKVLKSNPSENE	DNAJC3	126	Q13217
ETPAVSDSKEKKNAA	FAM193A	576	P78312
EDDNRASESKKPKTE	AFF4	771	Q9UHB7
QFTDKDKDNVAPRSK	ADM	126	P35318
TQKAKSEENTKEEKP	ST13P5	46	Q8NFI4
TQKAKSEENTKEEKP	ST13	46	P50502
KSPAEQKNLSDSGEE	RANBP3	26	Q9H6Z4
EEKEPQKNESSNASE	RANBP3	231	Q9H6Z4
KEAEFSDPENTRTKK	RBM20	871	Q5T481
PFKKQSATNLESEED	QSER1	976	Q2KHR3
EEEQQSKDDKNLSKP	IQCH	1011	Q86VS3
ANTTEDKPSKDDFQT	PPP4R3A	491	Q6IN85
DQELNKKPQDETKES	NOL11	561	Q9H8H0
SSVDEENKADEAKPK	ANK2	3331	Q01484
SQKQPAEKATSDDKD	ANKRD36C	581	Q5JPF3
QKQPAEKATSDEKDS	ANKRD36C	616	Q5JPF3
FDSLKSPDQKKENSS	DAB2	311	P98082
NGQDDTSKADKPKVD	PCGF5	106	Q86SE9
KNKKQEESADARAPS	FLII	456	Q13045
KVVKEEKANDSNPNE	LYVE1	281	Q9Y5Y7
EKANDSNPNEESKKT	LYVE1	286	Q9Y5Y7
SNPNEESKKTDKNPE	LYVE1	291	Q9Y5Y7
KASSQQEKEDKPAET	LIMA1	511	Q9UHB6
EEKSSSKPSNNAKDE	SPINK5	901	Q9NQ38
KSIDDNSTKSEKQTP	NCR3LG1	396	Q68D85
AQVSKDEEKKEAPDN	EDAR	231	Q9UNE0
TSEENKIPDADKANE	HSPH1	561	Q92598
QAQEKDSVNPSKDVD	CCDC190	156	Q86UF4
QEDNKEETKSKAKPV	FSIP2	1546	Q5CZC0
DATKEKPKEVAENQQ	EPB41L2	21	O43491
NKDDSASKLAPEEEA	MBD1	551	Q9UIS9
KEDDKSDTSSSQQPK	PCLO	1341	Q9Y6V0
KDTFKKDSQQDIPSS	PCLO	1476	Q9Y6V0
KDSQQDIPSSKDHKE	PCLO	1481	Q9Y6V0
EKSVQPLADEDSKSK	PDE1B	441	Q01064
ENIEDSNNPKTEKIK	EVI2B	296	P34910
AASQSDKPAEKKEDE	EVL	281	Q9UI08
SKVDTNKAHPDNKAE	NIPBL	926	Q6KC79
QPTSAEKSVAKKEDK	NANOG	76	Q9H9S0
KPKSQETLNSDDLDA	OR13C5	261	Q8NGS8
SEKTSDQDFTPEKKA	HDGFL2	196	Q7Z4V5
KDNTKSKEKESENAP	RBBP6	911	Q7Z6E9
SASDDQSDQKTTPKK	P4HA1	261	P13674
KEQNQTEKSLKSPSD	PALB2	346	Q86YC2
GNQEKKSEKPLENDT	RGPD3	931	A6NKT7
ATTPKPDKEKNTEEN	BOD1L1	936	Q8NFC6
PDKEKNTEENDSEKQ	BOD1L1	941	Q8NFC6
QKSVSDPVEDKKEQE	BOD1L1	2971	Q8NFC6
DSPKENEKAFSKTDE	CCSER2	451	Q9H7U1
ENEKSPSQNRKAKDA	FZR1	66	Q9UM11
KVKSENLKEEPQSSE	CHD9	2046	Q3L8U1
VQEKESDAVKPKNQD	CEP104	716	O60308
ENGDKSEAQKPSEKA	HYOU1	656	Q9Y4L1
KENNPSGKKELSEVE	KDM2A	776	Q9Y2K7
NTKESAAQSKPKEEL	KCNB1	546	Q14721
NEKSTENKKPQDSVL	C2orf83	126	Q53S99
DTASNENKEKNPIKE	CCDC125	436	Q86Z20
TDVEKPSKENESTKE	E2F7	686	Q96AV8
ENSKSTGAQPKEKEE	EFCAB6	1031	Q5THR3
KEAEKASSQEVAAPE	CEP89	286	Q96ST8
ESTEQKQSDIKKPEN	CEP97	506	Q8IW35
PDSKDEKQKLAETSS	CEP126	531	Q9P2H0
KKSSKNPEEAELEDT	CUL1	431	Q13616
TKEEEQKADPKEVSN	GALNT5	326	Q7Z7M9
EEVRSAENSSKSPKK	AXDND1	996	Q5T1B0
SQEKQTKKAEGEPQE	BCLAF1	161	Q9NYF8
PKDTELSQESDFKEN	AKAP5	306	P24588
KISKDSENKAIFPDN	ADPRHL1	236	Q8NDY3
IEPSSNKDDDFLEKN	ATF7IP	306	Q6VMQ6
KENVAETEKASSEAP	MGARP	96	Q8TDB4
NVSAEQKDENKEAKP	MARK3	641	P27448
LESEGKNSKKEEPQE	ATE1	151	O95260
ESIEKNKDKTDLPQS	CEP192	456	Q8TEP8
SASKQEKLPDEKETQ	CCDC168	876	Q8NDH2
DKPKEDGQSNDRISK	CCDC168	5781	Q8NDH2
PNAASDNASAEKKVK	CRYBG1	46	Q9Y4K1
PQKEKTKEDLDSRSN	CRYBG1	926	Q9Y4K1
DRPADKTSNEKNEVK	CCDC144A	571	A2RUR9
KQLQDTPSKISEDNK	ICA1L	261	Q8NDH6
LEPSKFSKQAAENEK	SLC39A10	46	Q9ULF5
TAASDQKQEEKPKPD	EIF4G3	211	O43432
DPQELESKFNSKTKA	KYAT3	196	Q6YP21
DSQKPQDQDKLSKED	CMTR1	811	Q8N1G2
SPQLKNDVSEEKDQK	LIMCH1	681	Q9UPQ0
NQEKKSEKPLENDTG	RGPD1	916	P0DJD0
KEAKESKENKEVSSP	UPF2	501	Q9HAU5
PRTSANSNKDKDKDE	PHF20L1	191	A8MW92
DKVQPKNNDKSEFLS	ORC2	146	Q13416
ADKLKEKEPQTQGES	SMG8	676	Q8ND04
DLVPDNSKTADNATK	RTRAF	101	Q9Y224
QDAEKSDTSPVAGKK	SYTL5	161	Q8TDW5
EFSSDEEIKKQQSPK	ARHGAP11A	716	Q6P4F7
NSEATKEAKESKKPE	RAB11FIP1	416	Q6WKZ4
TSPDRDKKKEQSEVS	RSRC2	16	Q7L4I2
NADKTPKAEEVKSSD	SPEF2	661	Q9C093
NTTEEKNKPSTEEKL	STK33	411	Q9BYT3
DIADVPSDTSKNDKK	PLCB4	861	Q15147
ESDEDNPIFKSRSKK	PHF2	881	O75151
PKQKKVVEAVNSDSD	TOP2B	1511	Q02880
KPKKTSFDQDSDVDI	TOP2B	1571	Q02880
DKLKVPESENNKTSN	MIA3	236	Q5JRA6
SSVAVNKSKPEDSKN	NCKAP5	1181	O14513
NSSRKEDDFKQKQPS	RFC1	46	P35251
SESEETLQVKNAKKP	RFC1	71	P35251
EKKSEKPLENDTGFQ	RGPD2	926	P0DJD1
DKTSSDSKDPADQIQ	RESF1	1091	Q9HCM1
EKEEATSNSPSKESK	TAF1	516	P21675
QPTSAENSVAKKEDK	NANOGP8	76	Q6NSW7
QPAKAESKDNKEIAS	NCOA1	576	Q15788
AVPESENVATKEQKK	PRDM15	616	P57071
KKIKNSPSEAQNLDE	SETD5	186	Q9C0A6
STVNSKEEKNPVKEE	SETX	1051	Q7Z333
VSTLKSPKADKVNDD	SHISA9	291	B4DS77
DDKEQPKATEAKARA	NAP1L3	261	Q99457
LDEKKKEPAITSQNS	TCEA1	86	P23193
SNAPKVSDEAVKKDS	PPM1B	296	O75688
KAEQDSDNKSSTEIP	RNF169	511	Q8NCN4
EKSDPKQEESQISGK	SPA17	81	Q15506
EDSDQASKPRQKAEK	STARD9	2496	Q9P2P6
EKEASNKEQPKVTNT	OCRL	191	Q01968
APDVTKLSDSNKENA	TRIOBP	1891	Q9H2D6
SDKEVETPEKKQNDQ	TLK2	46	Q86UE8
VSEKANPNIKDSKDN	APC	2686	P25054
TLKSKPQDTADKDAV	CFAP20DC	46	Q6ZVT6
EKEQKQESSKIPESS	CLMN	471	Q96JQ2
KSKETNKTDNTEAPV	SLC34A2	31	O95436
DREKDPNKASASTSK	TBX10	286	O75333
EDQTKAAEQKPSSKS	TIGD2	451	Q4W5G0
DKESETPEKKQSESS	TLK1	106	Q9UKI8
KKEKDISAPNDGTAQ	TDP1	111	Q9NUW8
EDVATKRSKPTEDNK	ZFHX4	1151	Q86UP3
DSKANVEVKNEEQKP	ZFHX4	1291	Q86UP3
GTEQEAAKNKKSPEI	THRAP3	661	Q9Y2W1
KVEENEQESKPAGSK	UNC80	966	Q8N2C7
SRKKSKEQNVSDDPE	TRPM6	586	Q9BX84
TKNEKTDKERTFDPE	SPEN	786	Q96T58
DDKASSKNDLQSPTE	SRGAP3	826	O43295
SKKADTKAQTDIDSP	TNN	786	Q9UQP3
KADTKAQTEIDGPKN	TNN	876	Q9UQP3
ESKKADTKAQTELDP	TNN	961	Q9UQP3
SEKKIKNSQPATDNF	SAGE2P	346	A6NJ88
DATEKDASKKSDSNP	RBM17	281	Q96I25
ESSLQEDEPENDAKK	TIMMDC1	251	Q9NPL8
DKKQNAQSSDESFEP	ZNF276	371	Q8N554
ASKEEKQQPKQDSTE	ZC3H12B	16	Q5HYM0
DKQPEEALSQAKKSV	NSD3	396	Q9BZ95
TAEPSDQKEKESEKQ	MAP2	171	P11137
KPKTAENQKASEENE	ZBTB20	6	Q9HC78
FPKNKEAASSQESED	ZNF469	1721	Q96JG9
VEDQNDSDSTPPKKK	ZEB1	881	P37275
KENKTPSSDAQDKQF	TSNAX	161	Q99598
NEKNDAELDSPPSKK	ZMYM6	721	O95789
PDSQSMEESKLKNDD	ZNF608	1301	Q9ULD9
KPKAQEDDVNSNLKD	ZGRF1	351	Q86YA3
QSPADLEEKKEEDSN	USP18	21	Q9UMW8
EPQNVDFSKELKKTE	PLEKHA5	986	Q9HAU0
ADQPKDDTKKTETDN	TUT4	591	Q5TAX3
ENSTRKDPSTTKDEK	ARHGAP21	1476	Q5T5U3
NNKEDEKAAKEDSQP	ZBTB40	691	Q9NUA8
FKKSPSSEKDRENNE	ZFP3	76	Q96NJ6
VSPKQKSVKDLEENS	MYO3A	1211	Q8NEV4